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Abstract 
  
3-Deoxy-D-arabino heptulosonate 7-phosphate synthase (DAH7PS) catalyses the first step of 
the shikimate pathway, responsible for the biosynthesis of aromatic amino acids. This 
pathway is found in microorganisms, plants and apicomplexan parasites and its absence in 
mammals makes it a viable target for antimicrobial drug design. DAH7PS enzymes differ in 
the regulatory machinery that decorates the catalytic (β/α)8 barrel. Some DAH7PS enzymes 
are fused to chorismate mutase (CM), another enzyme in the shikimate pathway. This fusion 
protein is allosterically regulated by chorismate (CA) or prephenate (PA), the precursor of 
tyrosine and phenylalanine. It has been suggested that DAH7PS enzymes evolved these 
extensions to the core barrel for the sole purpose of regulation.  
 
Geobacillus sp DAH7PS (GspDAH7PSWT) is a thermophilic type Iβ DAH7PS enzyme with an N-
terminal CM domain fused through a linker region. This thesis describes the functional 
characterisation work carried out on GspDAH7PSWT, in attempt to help determine how 
DAH7PS enzymes evolved such diverse methods of regulation. 
 
Chapter 2 describes the functional characterisation work carried out on the catalytic and 
regulatory domains of GspDAH7PSWT. The enzyme demonstrated both DAH7PS and CM 
activities with the DAH7PS domain determined to be metal dependent and most activated 
by Cd2+. PA completely inhibited the catalytic activity of GspDAH7PSWT, and AUC 
demonstrated an equilibrium exists between the dimeric and tetrameric quaternary states 
of the enzyme in solution. 
 
Chapter 3 describes the domain truncation of GspDAH7PSWT carried out at the linker region 
in order to obtain two separate protein domains, the catalytic domain lacking the N-
terminal domain (GspDAH7PSDAH7PS) and the regulatory domain without the catalytic 
domain (GspDAH7PSCM). Both variants were fully characterised, and information obtained 
from each domain was compared to the respective catalytic and regulatory domains of the 
wild-type enzyme, which was also characterised. Like GspDAH7PSWT, GspDAH7PSDAH7PS 
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showed greatest activation in the presence of Cd2+, with other metals having varying effects 
on activation rates and stability of the enzyme. Both truncated variants followed Michaelis-
Menten kinetics where GspDAH7PSDAH7PS was found to be more active than GspDAH7PSWT 
and unaffected by PA, whereas GspDAH7PSCM was a less efficient catalyst than the CM 
domain of GspDAH7PSWT. AUC demonstrated that in solution an equilibrium occurs between 
the monomeric and tetrameric oligomeric states of GspDAH7PSDAH7PS.  
 
Chapter 4 summarises the findings of the thesis along with future directions of this research, 
combining the results obtained and expanding upon them. It is concluded that the catalytic 
regulatory CM domain supports both protein structure and allosteric regulation of 
GspDAH7PSWT 
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1.Chapter 1 
 
Introduction 
 
1.1 The shikimate pathway 
Different organisms differ in their ability to synthesise amino acids that are essential for 
them to thrive. Amino acids are of great importance, serving as building blocks of proteins 
and as intermediates in metabolic pathways.1 Animals, unlike microorganisms, are unable to 
produce all the necessary amino acids, and therefore these amino acids need to be acquired 
by means of diet. Humans are only able to produce half of the required amino acids to 
support metabolism and therefore depend on food to supply the other half.2 Tyrosine (Tyr), 
phenylalanine (Phe) and tryptophan (Trp) are three amino acids not synthesised in animals 
that are synthesised via the shikimate pathway. This pathway operates exclusively in 
microorganisms, plants and apicomplexan parasites.3 
 
The shikimate pathway consists of a series of seven enzyme-catalysed reactions leading to 
the production of chorismate (CA), at which point branching of the shikimate pathway 
occurs towards a variety of aromatic end products (Figure 1.1).  
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Figure 1.1: Overview of shikimate pathway focusing on the key reactions involved in this project, 
including synthesis of chorismate prior to branching of the pathway and formation of the vital amino 
acids Tyr, Phe and Trp. Dashed arrows represent reactions that involve multiple steps. 
 
The shikimate pathway was elucidated by Davis and Sprinson along with their associates in 
the 1950s.4 The absence of the shikimate pathway in mammals has made the enzymes 
involved possible targets for herbicides and antimicrobial drug design.5-7 This means that 
inhibitors could be synthesised to target and halt the shikimate pathway in pathogenic 
organisms while having no effect on the animals that are being treated. 
 
1.2 3-Deoxy-D-arabino-heptulosonate 7-phosphate synthase 
The first step of the shikimate pathway is an ordered sequential aldol condensation reaction 
catalysed by the enzyme 3-deoxy-D-arabino-heptulosonate 7-phosphate synthase 
(DAH7PS).8 In this reaction, phosphoenolpyruvate (PEP) is coupled with a four carbon 
phosphorylated sugar, D-erythrose 4-phosphate (E4P), to form 3-deoxy-D-arabino-
heptulosonate 7-phosphate (DAH7P) and inorganic phosphate (Figure 1.1).9 
 
As a way of controlling the rate of production of shikimate pathway products, DAH7PS is 
often regulated by a feedback inhibition mechanism by the end products or intermediates 
3 
 
of the pathway. Different organisms have been shown to employ different strategies for 
regulating the biosynthetic activity of the shikimate pathway. DAH7PS enzymes from some 
sources are inhibited by Tyr, Phe or Trp, whereas others are inhibited by combinations of 
the aromatic amino acids.10,11 In some bacteria, DAH7PS is found to be fused to chorismate 
mutase (CM), a chorismate utilising enzyme on the branch to Phe and Tyr.12 The DAH7PS 
domain of this fusion protein is allosterically regulated by chorismate or prephenate (PA), 
the precursor to Tyr and Phe.13  
 
1.3 Different types of DAH7PS enzymes 
All DAH7PS enzymes share the same core (β/α)8 barrel fold.
14 However, there is 
considerable variation in the different small domain decorations that are attached to this 
catalytic barrel.15  These structural additions are responsible for the allosteric regulation of 
the enzyme through the binding of the biosynthetic pathway end products, with different 
enzymes demonstrating different mechanisms of inhibition.16-18 For some DAH7PS enzymes, 
the binding of inhibitors alter the enzyme’s conformation or dynamics leading to a change in 
the active site and thus preventing the substrates from binding.16 
 
The DAH7PS enzymes have been divided into two classes (type I and type II according to 
Jensen) depending on their molecular weight and amino acid sequence.19 Type I is further 
subdivided into Iα and Iβ subfamilies based solely on sequence similarity. There is a low 
sequence similarity between individual members of subtypes Iα and Iβ, (approximately 18 
%) suggesting limited homology between the two subfamilies (Figure 1.2).18 Type Iα DAH7PS 
enzymes are generally larger (approximately 40 kDa) than type Iβ DAH7PS enzymes 
(approximately 30 kDa). Both subtypes however are smaller than type II DAH7PS (>54 kDa) 
enzymes.20,21 
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Figure 1.2: The different DAH7PS families showing the monomer fold of previously characterised 
DAH7PS enzymes. The core (β/α)8 barrel is shown in cyan with internal and external extensions 
shown in yellow and red, respectively. 
 
While subtypes Iα and Iβ belong to the same DAH7PS family and catalyse the same reaction, 
based upon sequence identity, subtype Iβ DAH7PS enzymes are functionally and structurally 
more closely related to 3-deoxy-D-manno-octulosonate 8-phosphate synthase (KDO8PS) 
enzymes (IβK) than to the DAH7PS enzymes of subtype Iα.
20 
 
DAH7PS and KDO8PS are two functionally unrelated enzymes with low sequence similarity, 
yet they have features in common such as mechanism and structure.22 KDO8PS catalyses a 
reaction analogous to that of DAH7PS, condensing D-arabinose 5-phosphate (A5P) instead of 
E4P with PEP to form 3-deoxy-D-manno-octulosonate 8-phosphate (KDO8P) and inorganic 
phosphate.23 This is an important reaction that produces 3-deoxy-D-manno-octulosonate 
 
 
  
 
DAH7PS  
Type I  Type II 
Type Iα Type Iβ 
EcoDAH7PS 
TmaDAH7PS 
PfuDAH7PS 
MtuDAH7PS 
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(KDO), a product that is necessary for the biosynthesis of lipopolysaccharides that are 
required for the growth of Gram negative bacteria (Figure 1.3).24 
 
 
Figure 1.3: Condensation of PEP and A5P catalysed by KDO8P synthase. 
 
1.4 Catalytic mechanism 
Numerous details have been obtained about the reaction mechanism of DAH7PS through 
extensive studies (Figure 1.4). Originally it was thought that the reaction between PEP and 
E4P occurred through a ping-pong mechanism.25 This was later disproven by another study 
showing that the reaction followed an ordered sequential kinetic mechanism. 
 
 
Figure 1.4: DAH7PS catalysed condensation mechanism of PEP and E4P, to form DAH7P. 
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This mechanism proceeds in a stereospecific manner where PEP binds to the enzyme first, 
followed by E4P,26 with the si face of PEP coupling with the re face of E4P to produce DAH7P 
(Figure 1.5).27,28 This is followed by water attack on the oxocarbenium ion, phosphate loss, 
and finally DAH7P release.26 
 
 
Figure 1.5: DAH7PS catalysed stereospecific reaction of PEP and E4P. 
 
The loss of phosphate from PEP occurs through the cleavage of the C-O bond instead of the 
P-O bond of PEP. This is unusual due to the high energy contained in the phosphate ester 
bond that could be utilised by the enzyme catalysed reaction.26 The oxygen at C2 of DAH7P 
is therefore obtained from water which attacks at C2 of PEP. 
 
It is thought that the first step of the reaction, where C3 of PEP attacks C1 of E4P, is 
activated by the coordination of its carbonyl group to an essential divalent metal ion, to 
form the oxocarbenium ion intermediate (Figure 1.6).29 An active site water is then believed 
to attack the re face of the intermediate to form a phosphate hemiketal intermediate. This 
intermediate loses its phosphate through C-O bond cleavage to form DAH7P. This seven 
carbon sugar is then thought to be released from the enzyme in an acyclic form that 
spontaneously equilibrates to a more stable cyclic pyranose form.30 
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Figure 1.6: Mechanism showing the proposed role of the metal ion in the active site of DAH7PS. 
 
1.5 Metal activation 
While both metal dependent and metal independent KDO8PS enzymes have been 
characterised, all DAH7PS enzymes characterised to date have been dependent on a 
divalent metal ion for catalysis. 31-35 
 
The presence of the metal chelator ethylenediaminetetraacetic acid (EDTA) causes most 
DAH7PS enzymes characterised to date to lose activity. Activity is restored upon the 
addition of divalent metal ions.7,12,13,36 Sequence alignment studies show all known DAH7PS 
enzymes contain a set of conserved metal binding residues (Cys, His, Glu and Asp) that 
contribute to the coordination of the metal ion.37,38 Metal independent KDO8PS enzymes 
have been shown also to have the conserved metal binding residues, however Cys has been 
substituted to Asn. An example of this is observed in Escherichia coli KDO8PS, a metal 
independent enzyme, which contains an Asn instead of Cys as part of the conserved metal 
binding residues.22 A study was carried out where Asn was substituted with Cys, resulting in 
a variant with increased enzymatic activity in the presence of divalent metal.  
 
Whereas all DAH7PS enzymes require metal for enzyme catalysis, a number of different 
divalent metal ions including Mn2+, Cd2+ and Zn2+, are able to activate the enzyme. Some 
metal ions are found to be more activating than others, depending on the source of the 
enzyme.6,13,15,39,40 This variation in metal selection is also the case in the different isozymes 
of the same organism. An example of this involves the Tyr-regulated DAH7PS isozyme of 
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Saccharomyces cerevisiae (SceDAH7PS) which is most activated by Cd2+, whereas the Phe-
regulated isozyme demonstrates the highest catalytic activity in the presence of Mn2+.31 
 
1.6 Structure of DAH7PS 
Obtaining crystal structures of DAH7PS enzymes can provide a great amount of detail about 
the enzyme that is unobtainable with functional studies. The crystal structure allows for 
visual inspection, helping to determine the way in which the enzyme is folded, the position 
of monomeric units and how they interact with one another.7,37,41  
 
Type 1α 
The genome of E. coli encodes for three DAH7PS isozymes (EcoDAH7PS). All three isozymes 
are classified as 1α subfamily of DAH7PS enzymes, with each being specifically inhibited by 
only one aromatic amino acid from the shikimate pathway. Sequence analysis determined 
that the three isozymes are similar in molecular weight, sequence and polypeptide chain 
length.37 
 
The crystal structure of the isozyme inhibited by Phe (EcoDAH7PS(Phe)), was the first 
structure of a DAH7PS enzyme to be solved.37 The enzyme crystallised as a tetramer 
consisting of a dimer of two tight dimers (Figure 1.7). Association of the subunits in the tight 
dimer is significantly enhanced due to the formation of a three stranded, antiparallel β 
sheet involving the N-terminal β0 strand of one monomer and the extended β6a- β6b 
strands of the adjacent chain. 
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Figure 1.7: Tetrameric structure of EcoDAH7PS (PDB code 1KFL) with different colours representing 
individual monomers.  
 
Each chain of EcoDAH7PS(Phe) contains a (β/α)8 triosephosphate isomerase (TIM)-barrel 
and this structure is observed for all other DAH7PS enzymes characterised to date.7,11,13,31 
The active site of this fold is located at the C-terminal end of the barrel.42 Extended loops 
that connect helices and strands at the C-terminal (β-α loops) harbour the residues that 
make up the active site for the binding of the metal ion and the substrates PEP and E4P. 
These loops are longer than those at the N-terminal end of the barrel (α-β loops).  
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Figure 1.8:  Monomeric structure of EcoDAH7PS (PDB code 1KFL) showing the core (β/α)8 barrel 
(cyan), with the N-terminal extension (red) and internal extension (yellow). 
 
The crystal structure of EcoDAH7PS(Phe) also shows that each subunit is enhanced by a 53 
residue long N-terminal extension, along with a two-stranded antiparallel β-sheet β6a/β6b 
inserted between the α5 and β6 strands of the barrel (Figure 1.8).37 These additions to the 
core barrel have been shown to be involved in feedback regulation of the enzyme and 
provide an allosteric binding site for Phe.8,43 
 
Type Iβ 
The crystal structure of Thermotoga maritima DAH7PS (TmaDAH7PS) was the first structure 
to be solved for a Iβ DAH7PS enzyme.41 The enzyme, like subtype Iα DAH7PS enzymes, 
contains the core (β/α)8  barrel with a similar active site architecture. It was shown that 
TmaDAH7PS forms a tetramer made up of two dimers associating through helices α5-α8 and 
loops β5-α5, β6-α6, and β7-α7. 
 
Each core barrel has a two stranded hairpin and an N-terminal ferredoxin-like (FL) domain 
consisting of a distinctive βαββαβ fold connected to the barrel though a flexible linker, 
which was determined to be involved with feedback regulation of the enzyme (Figure 1.9).16  
β0 
α00 
α1 
α8 
α7 
α6 
α5 
α4 
α3 
β6a 
β6b 
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The FL domain is notably similar to the ACT domain, found fused to a number of other 
enzymes involved in amino acid biosynthesis, for the purpose of ligand binding and 
regulation.44 Recognised as a recurring motif among a diverse group of proteins in 1999,45 
the ACT domain was named after the first letters of three proteins, aspartate kinase, 
chorismate mutase and tyrA (prephenate dehydrogenase), in which it was originally 
identified. 
  
Figure 1.9: Monomeric (left) and tetrameric (right) structure of TmaDAH7PS (PDB code 1RZM). 
Monomeric structure shows the core (β/α)8 barrel (cyan) with the N-terminal extension (red). The 
tetrameric structure is shown with different colours representing individual monomers. 
 
Another Iβ enzyme is that of Pyrococcus furiosus DAH7PS (PfuDAH7PS).14 This enzyme also 
crystallises as a tetramer, with each subunit consisting of the (β/α)8  barrel with the two 
stranded hairpin similar to the subunit of TmaDAH7PS. PfuDAH7PS lacks the ferredoxin-like 
of TmaDAH7PS, however its crystal structure consists of the same tetrameric structure as 
TmaDAH7PS (Figure 1.10). 
 
Similar to PfuDAH7PS, Aeropyrum pernix DAH7PS (ApeDAH7PS) lacks any added external or 
internal decorations to the (β/α)8  barrel. The crystal structure of ApeDAH7PS shows that the 
enzyme forms the same tightly associated tetramer as PfuDAH7PS and TmaDAH7PS (Figure 
1.10).15  
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Figure 1.10: Tetrameric crystal structures of PfuDAH7PS (PDB code 1ZCO) (left) and ApeDAH7PS 
(PDB code 1VS1) (right) with different colours representing individual monomers. 
 
Type II 
The crystal structure of Mycobacterium tuberculosis DAH7PS (MtuDAH7PS) has been solved 
and is the, being the first only type II DAH7PS enzyme structure to be determined. The 
structure shows that the enzyme consists of two tight dimers that interact to form a 
homotetramer.7  
 
 
Figure 1.11: Monomeric (left) and tetrameric (right) structures of MtuDAH7PS (PDB code 3NV8) 
showing the core (β/α)8 barrel (cyan), with the N-terminal extension (red) and internal extension  
(yellow) for the monomer and different colours representing different monomers for the tetramer. 
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As for the type I DAH7PS enzymes, this structure shows that each subunit consists of the 
same (β/α)8 barrel (Figure 1.11). Unlike type Iα and Iβ DAH7PS enzymes, MtuDAH7PS 
contains two additional decorations to the core barrel that play a role in the allostery of the 
enzyme.11,14,15 one extension consists of a  β-strand followed by three helices extending 
from the N-terminus closing off the end of the barrel, with another extension consisting of 
two helices, extending the α2-β3 connecting loop.46   
 
1.7 Active site of DAH7PS 
Although the different types of DAH7PS enzymes (type Iα, Iβ, and II DAH7P synthases) have 
low overall sequence similarity, they all share the (β/α)8 barrel fold housing the catalytic 
machinery. Many of the residues that contribute to the active site are also common to all 
types of DAH7PS enzymes. The ordered sequential aldol condensation reaction involves the 
coupling of PEP and E4P to form DAH7P with a requirement for a divalent metal ion for the 
reaction to proceed. Three positively charged arginine (Arg) and two lysine (Lys) residues 
position the negatively charged PEP through hydrogen-bonding and salt bridge 
interactions.47 These residues are conserved across all DAH7PS enzymes and in EcoDAH7PS, 
the residues involved in PEP binding are Arg92, Arg165, Arg234, Lys97 and Lys196 (Figure 
1.12).37  
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Figure 1.12: PEP binding site of EcoDAH7PS(Phe) (PDB code 1N8F) showing interaction (dashed lines) 
of residues (grey) with PEP (orange/green). 
 
In the ordered sequential reaction carried out by DAH7PS, E4P is the second substrate to 
bind.18 A crystal structure of TmaDAH7PS was solved with PEP and E4P bound.41  Another 
crystal structure of SceDAH7PS was obtained with PEP and glycerol 3-phosphate (G3P) 
bound.47 These data gave a better understanding of the residues involved with the binding 
of E4P. E4P binding is mediated with the residues Lys, Pro, Arg (Thr/Ser), a conserved motif 
found in all DAH7PS enzymes. For EcoDAH7PS, the residues involved in E4P binding are 
Lys97, Pro98, Arg99 and Thr100. 
 
In the active site, a divalent metal ion coordinates near the C-terminal end of the barrel.37 
An example of this is in EcoDAH7PS, where the divalent metal ion is coordinated in a 
distorted bi-pyramidal geometry to the residues Cys61, His268, Glu302 and Asp 326 (Figure 
1.13). 
 
Lys186 Arg92 
Lys97 
Arg165 
Arg234 
Ala164 
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Figure 1.13: Metal binding site of EcoDAH7PS (PDB code 1N8F) showing water molecule (red) and 
metal ion (purple) coordinated to metal binding residues (grey). 
 
1.8 DAH7PS regulation  
Different methods of controlling the quantity of products formed are important to an 
organism as it ensures that biosynthesis of products only occurs as a response to metabolic 
demand. It is therefore in the best interest of the organism to control the rate at which 
products are being formed to prevent the wastage of resources. The main way that the 
shikimate pathway is controlled is through feedback regulation of DAH7PS by pathway 
intermediates or end products. For some types of DAH7PS enzymes, binding of these 
molecules remote to the active site leads to a conformational change that alters the active 
site, halting the enzyme from performing its intended function. Different species have 
employed different ways in how DAH7PS is regulated, with each type of enzyme appearing 
to have a unique method of allostery.11,13,16  
 
All regulated DAH7PS enzymes from different organisms contain different types of 
decorations attached to the core (β/α)8 barrel. Obtaining crystal structures of DAH7PS 
enzymes has been very useful in determining the mechanism of allosteric inhibition 
Cys 
His 
Glu 
Asp 
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employed by the enzyme. A visual inspection of the decorations shows how they are folded, 
and can give some insight as to where allosteric inhibitors bind.  Structural comparisons of 
ligand bound and non-ligand bound DAH7PS enzymes have also helped to determine the 
conformational changes that the enzyme undergoes upon ligand binding.11,16 
 
Each of the three isozymes of EcoDAH7PS is feedback regulated by one of the three 
aromatic amino acids (Phe, Tyr and Trp) of the shikimate pathway. It has been shown that 
EcoDAH7PS(Phe) accounts for most of the DAH7PS activity (approximately 80 %) in E. coli, 
while EcoDAH7PS(Tyr) accounts for 20 %. The EcoDAH7PS(Trp) isozyme has the lowest 
contribution with less than 1 % of total DAH7PS activity.48 Salmonella typhimurium and 
Neurospora crassa also produce three DAH7PS isozymes, whereas S. cerevisiae only 
produces two isozymes regulated by Phe and Tyr.49 
 
A crystal structure of EcoDAH7PS(Phe) shows that the N-terminal extension and the internal 
extension located between the α5 and β6 strands of the (β/α)8 barrel create a single binding 
site for the inhibitor to bind to and inhibit the enzyme.8,43 Comparisons of the ligand bound 
and non-ligand bound crystal structures of EcoDAH7PS(Phe) show that barely any 
conformational changes occur upon ligand binding (root-mean-square deviation (RMSD) of 
0.7 Å between equivalent subunits), except for a slight disturbance in two active site loops 
involved in substrate binding (Figure 1.14). Two interconnected routes of conformational 
changes transmit from the allosteric Phe-binding site to the active site of DAH7PS. The 
transmitted conformational changes alter the ability of EcoDAH7PS to interact with its 
substrates, and is therefore no longer able to bind E4P, while only being able to bind PEP in 
a flipped conformation. 
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Figure 1.14: Superposition of a non-ligand bound (PDB code 1QR7) and ligand bound (PDB code 
1KFL) crystal structure of EcoDAH7PS monomers. The non-ligand bound structure is shown in dark 
blue with the N-terminal and internal barrel extensions shown in red and orange respectively. The 
ligand bound structure is shown in cyan the N-terminal and internal barrel extensions shown in 
magenta and yellow respectively. The ligand Phe is shown as sticks coloured green with the metal 
ion shown as a purple sphere. 
 
Some DAH7PS enzymes are simply unregulated. Belonging to the Iβ subfamily, PfuDAH7PS 
and ApeDAH7PS have been structurally and functionally characterised, and have been found 
to consist of only the core (β/α)8 barrel with no added decorations (Figure 1.15).
14,15 
Interestingly, both enzymes show no signs of regulation with none of the shikimate pathway 
products tested inhibiting the activity of the enzymes. This is unlike other Iβ subfamily 
DAH7PS enzymes that have evolved extensions to the core barrel that contribute to the 
regulation of the enzyme. 
Phe 
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Figure 1.15: Monomeric structure of PfuDAH7PS (left) (PDB code 1ZCO) and the monomeric 
structure of ApeDAH7PS (right) (PDB code 1VS1) showing the core (β/α)8 barrel (cyan) with the N-
terminal extension (red). 
 
TmaDAH7PS is strongly inhibited by Tyr and by Phe to a lesser extent.38 Forming a truncated 
variant by the removal of N-terminal domain not only produced an enzyme that was 
catalytically more active, but one that was unaffected by Tyr or Phe. Furthermore, a crystal 
structure obtained of TmaDAH7PS in the presence of Tyr revealed that pairs of the 
regulatory domains from diagonally opposite subunits come together, forming a binding site 
for Tyr (Figure 1.16).16 This reorganisation in the structure of TmaDAH7PS leads to the 
capping of the active site to restrict substrate binding, leading to enzyme inhibition. This 
showed that the FL domain was responsible for feedback regulation. More interestingly, a 
study carried out where the FL domain from TmaDAH7PS was fused to the unregulated 
PfuDAH7PS, resulted in an enzyme that became regulated by Tyr and to a lesser extent by 
Phe.50 
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Figure 1.16: Crystal structure of TmaDAH7PS with Tyr bound (PDB code 3PG9). Different colours 
represent different monomers with Tyr ligands shown as sticks and coloured magenta.  
 
The M. tuberculosis genome encodes for only one DAH7PS enzyme. This sole type II DAH7PS 
possesses a method of regulation much more complicated in comparison to other DAH7PS 
enzymes.46 MtuDAH7PS demonstrates little sensitivity to the three aromatic amino acids 
individually, yet significantly increased inhibition of the enzyme is observed in the presence 
of combinations of two or more different amino acids. These amino acids bind to the 
decorations that extend from the core (β/α)8  barrel. This synergistic type of inhibition 
allows for precise control over the quantity of end products being produced. More recently 
it was determined that while the combination of Phe and Trp caused significant inhibition of 
the enzyme, the addition of Tyr to the inhibitory couple led to almost complete loss of 
enzymatic activity.11  
 
A ligand bound crystal structure of MtuDAH7PS shows that there are three distinct allosteric 
binding sites for each aromatic amino acid.11 Two of the allosteric sites are in the dimer and 
tetramer interfaces with the third binding site being located near the dimer interface on the 
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outside surface of the enzyme. Furthermore ligand bound and ligand free crystal structure 
comparisons of MtuDAH7PS show no significant change in conformation of the enzyme 
(Figure 1.17).46 Molecular dynamics simulation studies determined that the binding of 
ligands, caused a substantial increase in flexibility of the loop that forms part of the binding 
site for E4P.17 This increased flexibility may mean that binding of the substrate E4P is 
entropically unfavourable, and may be the mechanism by which inhibition of the enzyme is 
achieved. 
 
 
Figure 1.17:  Superposition between a non-ligand bound (PDB code 2B70) and ligand bound (PDB 
code 3KGF) subunit of MtuDAH7PS. The non-ligand bound structure is shown in dark blue with the 
N-terminal and internal barrel extensions shown in red and orange respectively. The ligand bound 
structure is shown in cyan the N-terminal and internal barrel extensions shown in magenta and 
yellow respectively. The ligands, Phe and Trp are shown as sticks coloured grey and green 
respectively with the metal ion shown as a purple sphere. 
 
1.9 Chorismate mutase (CM) 
Chorismate, the last compound produced in the main trunk of the shikimate pathway and at 
the branch point to a range of other aromatic metabolites, is the common precursor for vital 
Phe 
Phe 
Trp 
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aromatic amino acid biosynthesis.  After the shikimate pathway branches, one branch leads 
to the formation of anthranilate and thereon to Trp, whereas the other branch leads to the 
formation of prephenate, the precursor for both Tyr and Phe.51  
 
Chorismate mutase (CM), first identified in 1965,52 catalyses the conversion of chorismate to 
prephenate (Figure 1.18). Different types of CM enzyme structures can be found in different 
microorganisms, with most being grouped into the AroQ family and the rest being grouped 
into the AroH family. First observed in E. coli,53 CM enzymes in the AroQ family are 
widespread and are mainly homodimeric, with each chain consisting of three α-helices 
connected by two turns (Figure 1.19).54,55 CM enzymes in this family can be monofunctional 
or bifunctional. Being bifunctional means having the ability to catalyse two different 
reactions through two different catalytic sites found in a single protein chain. This occurs 
when CM is connected to another enzymatically active domain. Bifunctional AroQ CM 
domains were found to be fused to different enzymes such as prepehenate dehydratase, 
prephenate dehydrogenase or DAH7PS.56,57  
 
 
Figure 1.18: Conversion of chorismate to prephenate catalysed by chorismate mutase. 
 
 
The other type of chorismate mutase enzymes are grouped into AroH family, characterised 
by a trimeric α/β barrel structure (Figure 1.19).58,59 Chorismate mutase enzymes in this 
family are monofunctional as they are never fused to other functional domains like 
monofunctional AroQ enzymes, and therefore contain a single active site located at the 
monomer interfaces. 
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Figure 1.19: AroQ CM dimer structure (left) of E. coli (cyan and red) (PDB code 1ECM) and AroH CM 
trimer structure from Bacillus subtilis with (cyan, red, green) (PDB code 2CHT) 
 
1.10 CM and DAH7PS fusion proteins 
A slightly active CM domain covalently fused to the N-terminus of a subtype Iβ DAH7PS 
enzyme was first identified in Bacillus subtilis (BsuDAH7PS).58 The CM domain fused to the 
DAH7PS domain plays a role in regulating DAH7PS activity through feedback regulation. This 
occurs through binding of the branch point intermediates (chorismate and prephenate), to 
the CM domain, altering the DAH7PS domain active and leading to enzyme inhibition.12,13,60  
 
Other characterised DAH7PS enzymes in different organisms, such as Porphyromonas 
gingivalis (PgiDAH7PS),12 and Listeria monocytogenes (LmoDAH7PS),61 also display fusion to 
an ancillary CM domain, with PgiDAH7PS shown to be inhibited by prephenate and 
chorismate (Figure 1.20). It is thought that organisms evolved these fusion proteins for the 
sole purpose of regulation rather than to provide bifunctionality.12 BsuDAH7PS was found to 
exhibit both DAH7PS activity and extremely low CM activity.13 It was determined however 
that B. subtilis contains another gene encoding for a second intracellular AroH CM domain 
responsible for the conversion of CA to PA.60 This AroH CM is highly active, unlike the AroQ 
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CM which is redundant in activity by comparison and is really an ancillary to this other CM 
domain. 
 
To provide further knowledge on the evolution of these fusion proteins, a study was carried 
out where the DAH7PS and CM domains of BsuDAH7PS were separated by domain 
truncation.13 The same study also examined the alternate fusion protein PgiDAH7PS that 
also exhibited DAH7PS activity and low CM activity, in which the CM domain extension is 
fused C-terminal end of the catalytic barrel.12 A domain truncation was also carried out on 
this enzyme and the results obtained were used for comparative studies. Results 
determined that the DAH7PS truncated variants from both enzymes only demonstrated 
DAH7PS activity. The CM truncated domain from BsuDAH7PS only demonstrated CM 
activity, while the CM truncated domain from PgiDAH7PS did not demonstrate DAH7PS or 
CM activity. Interestingly, whereas both wild-type enzymes were inhibited by prephenate 
and chorismate, the DAH7PS truncated mutants from both enzymes showed no signs of 
inhibition. In comparison to prephenate, chorismate was found to be a much weaker 
inhibitor for BsuDAH7PS, with a sigmoid curve inhibition pattern in response to increasing 
concentrations of chorismate. It is believed that the weak inhibition pattern observed by 
chorismate is due to the weakly active CM domain converting the substrate to prephenate, 
which in turn acts as the true inhibitor of BsuDAH7PS. Intracellularly, chorismate would be 
converted to prephenate at a much faster rate due to the other AroH CM protein that is 
highly active in B. subtilis, leading to the inhibition of the enzyme. The results obtained 
presented compelling evidence that these organisms evolved these fusion proteins for the 
sole purpose of regulation instead of bifunctionality.13 
 
LmoDAH7PS is another fusion protein that consists of the core (β/α)8 barrel most similar to 
the catalytic barrel domain of TmaDAH7PS, with 55 % sequence identity.41,61 The core barrel 
is fused to a CM domain through a linker region at the N-terminus. The crystal structure of 
the enzyme shows that it forms a tetramer with two CM domains emerging from diagonally 
opposite sides of the tetramer and to form a CM dimer (Figure 1.20). The CM dimers on 
each side of the tetramer are believed to stabilise the tetrameric state of the enzyme in the 
same way the FL domains stabilise TmaDAH7PS. It is thought that the CM dimers are loosely 
associated with the DAH7PS tetramer where binding of prephenate or chorismate to the 
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regulatory domain would lead to a conformational change. This proposed conformational 
change may cause catalytic and regulatory domain interactions, either blocking the active 
site, or inducing conformational changes in the catalytic domain.61 
 
Another type of interaction between CM and DAH7PS was discovered for M. tuberculosis, 
which differed from the others in that it is a non-covalent interaction between independent 
CM and DAH7PS proteins.62 The genome of M. tuberculosis encodes for a weakly active 
chorismate mutase domain (MtuCM). This weak enzymatic activity was accounted for by the 
absence of some of the conserved active site residues present in the AroQ family. It was 
determined that upon complex formation between MtuCM and MtuDAH7PS, MtuCM 
became much more active with a more than a 100 fold increase in catalytic activity, whereas 
MtuDAH7PS activity was unaffected. In the presence of Phe, Tyr or Trp, MtuCM showed no 
signs of inhibition. Upon complex formation with MtuDAH7PS, Phe and Tyr inhibited the 
enzyme by 70 % and 40 % respectively, with synergistic inhibition occurring In the presence 
of both aromatic amino acids, almost completely abolishing CM enzymatic activity.63  
 
A crystal structure of the protein complex showed that CM dimers associated with opposite 
ends of the MtuDAH7PS tetramer (Figure 1.20). Inspection of the crystal structure revealed 
that MtuDAH7PS does not supply residues to the active site of MtuCM to increase activity, 
however it causes a conformational change in MtuCM that leads to a displacement of 
residues in the active site for more favourable catalysis.63 
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Figure 1.20: Tetramer structure of LmoDAH7PS (PDB code 3TFC) (left), and MtuDAH7PS-CM (PDB 
2W19) (right) complex with different colours representing different monomers, each fused to an N-
terminal CM domain through a linker region.  
 
1.10.1 Geobacillus sp DAH7PS 
Geobacillus sp is a Gram negative bacterium which is a thermophile, and thrives in a variety 
of locations at temperatures as high as 75 ᵒC.64 Sequence analysis, along with a crystal 
structure of Geobacillus sp DAH7PS (GspDAH7PSWT),65 shows that this enzyme also has fused 
to the CM domain at the N-terminus (Figure 1.21). 
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Figure 1.21: Tetramer structure of GspDAH7PSWT at different angles, with different colours 
representing different monomers, each fused to an N-terminal CM domain through a linker region.  
 
GspDAH7PSWT crystallises as a tetramer, where the quaternary structure is held together by 
the CM domains from diagonally opposite sides of the tetramer interlocking with one 
another, in a similar way to the LmoDAH7PS structure. Each subunit consists of the core 
(β/α)8 barrel bound to a CM domain on the N-terminus through a flexible linker (Figure 
1.22). This CM domain is thought to play a role in the regulation of the enzyme.  
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Figure 1.22: Monomeric structure of GspDAH7PSWT showing the core (β/α)8 barrel  (cyan) with the N-
terminal CM regulatory domain (red), connected through a linker region (not shown due to lack of 
electron density). 
 
1.11 Objectives of thesis 
The aim of this project was to contribute towards the research previously carried out on 
DAH7PS enzymes, in order to determine how these enzymes evolved such diverse methods 
of regulation. The idea that these enzymes have recruited a variety of regulatory machinery, 
by attaching small regulatory domains to the core barrel for the sole purpose of feedback 
regulation was tested. This hypothesis was examined by carrying out a domain truncation of 
the type Iβ GspDAH7PSWT at the linker region, in order to obtain a catalytic domain lacking 
the N-terminal domain (GspDAH7PSDAH7PS), and a regulatory domain without the catalytic 
domain (GspDAH7PSCM). After separating the catalytic and regulatory domains, both 
variants were fully characterised, and information obtained from each domain was 
compared to the respective catalytic and regulatory domains of the wild-type enzyme, 
which was also characterised in studies described in this thesis. 
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This study aimed to: 
 Determine if the regulatory CM domain does in fact contribute to allosteric 
regulation of the enzyme, and if so, help predict the likely mechanism of inhibition. 
 Investigate if the CM domain plays a role in the quaternary structure of the wild-type 
enzyme and what effects the removal of this catalytic domain has. 
 Gain more insights to the different modes of regulation of the DAH7PS enzymes.    
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2.Chapter 2 
 
Purification and biochemical characterisation 
of type Iβ Geobacillus sp DAH7PS 
 
2.1 Overview 
The genome of the thermophile Geobacillus sp, encodes for a type Iβ DAH7PS enzyme 
consisting of a catalytic domain fused to a regulatory CM domain, as determined by 
sequence analysis and the structure of the enzyme.65 The aim of the work described in this 
chapter was to fully characterise the wild-type enzyme and examine in detail both the 
independent regulatory and catalytic domains. Data obtained has been used for 
comparative studies with previously characterised DAH7PS enzymes, particularly to other 
CM fused DAH7PS enzymes. The information gained by this study provides a greater 
understanding of how these enzymes evolved to incorporate the regulatory decorations to 
the core barrel. 
 
The initial characterisation of GspDAH7PSWT begun by the expression and purification of the 
enzyme. Differential scanning fluorimetry (DSF), metal activation, temperature dependency 
and kinetic study experiments were then carried out. DSF determined the stabilising effects 
different additives had on GspDAH7PSWT. Metal activation and temperature dependency 
studies were conducted to determine the most activating metal ion for the enzyme, and the 
temperature for highest enzymatic activity.  Kinetic studies involved obtaining Michaelis-
Menten constants and carrying out an inhibition study to determine if the enzyme is 
inhibited. Analytical ultracentrifugation was used to determine the quaternary structure of 
the enzyme in solution. 
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2.2 Expression and purification 
The purification protocol for GspDAH7PSWT (with a C-terminal non cleavable hexaHis-tag 
ligated into the PET-28b (+) vector) was developed with reference to its predicted heat 
stability and calculated isoelectric point (pI) of 5.99. E. coli cells containing the plasmid 
encoding for GspDAH7PSWT were grown, induced with isopropyl-1-thiol-β-D-
galactopyranoside (IPTG), harvested and lysed. The lysed cells were heat treated at 60 ᵒC for 
30 minutes and left to cool to room temperature in an attempt to remove other 
contaminating proteins. Since GspDAH7PSWT is naturally expressed in a thermophilic host,64 
it was expected to able to withstand heat treatment, while other proteins originating from 
E. coli host cells would denature. The heat-treated supernatant was centrifuged to remove 
cell debris and precipitated protein. The resulting supernatant required further purification 
steps to remove remaining contaminants (Figure 2.1). 
 
Figure 2.1: SDS-PAGE analysis for GspDAH7PSWT before induction (lane 1), after induction (lane 2), 
whole cells containing GspDAH7PSWT (lane 3) after lysis and heat treatment (lane 4), and in the 
supernatant after centrifugation (lane 5). 
 
Since GspDAH7PSWT contains a C-terminal hexaHis-tag, a nickel-based affinity column was 
used in the next purification step. The supernatant was loaded onto the column in buffer 
containing a low imidazole concentration (20 mM) and eluted using a linear gradient of 
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increasing imidazole concentration. The eluted fractions containing GspDAH7PSWT (as 
determined by SDS-PAGE) were collected, concentrated, and then the protein was further 
purified using size exclusion chromatography (SEC). The protein eluted from the SEC column 
in a single peak with a shoulder to the right of the peak (Figure 2.2).  
 
 
Figure 2.2: SEC trace of eluted GspDAH7PSWT in SEC buffer (10 mM BTP, pH 7.4, 40 mM KCl, 200 µM 
PEP and 10 µM EDTA) showing the protein peak with a shoulder to the left of the peak. Numbers 1 
to 8 represent the lane number on the SDS-PAGE gel of where the fractions from the SEC run were 
taken (Figure 2.3). 
 
 
SDS-PAGE analysis determined that both the peak and its shoulder represented a protein 
with a molecular mass corresponding to GspDAH7PSWT (Figure 2.3). The peak and the 
shoulder both contained DAH7PS activity as determined by enzyme activity assays, 
suggesting GspDAH7PSWT had been purified. Fractions corresponding to the larger peak only 
were collected, concentrated, divided into aliquots, flash frozen using liquid nitrogen, and 
stored at -80 ˚C. 
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Figure 2.3: SDS-PAGE gel of final collected fractions after SEC of GspDAH7PSWT Lanes 1-4 showing 
fractions collected from the peak (Figure 2.2). Lanes 5-8 showing fractions collected from the 
shoulder. 
 
2.3 Mass spectrometry 
The molecular mass of GspDAH7PSWT was determined using electrospray ionisation mass 
spectrometry to ensure the purified enzyme was of the expected mass calculated from the 
amino acid sequence using ProtPram. The enzyme had a mass of 41,373 Da, which is in close 
agreement with the calculated mass of 41,374 Da. 
 
2.4 Differential scanning fluorimetry  
To investigate the heat stability of GspDAH7PSWT and to probe any changes to the thermal 
stability of this protein under different conditions (no metal-control, EDTA, Co2+, Cd2+, Zn2+, 
Mg2+, Ni2+, Pb2+, Ca2+, chorismate and prephenate). DSF experiments were carried out to 
determine the protein denaturation temperatures (Tm) (Figure 2.4). This method utilises a 
dye that fluoresces in the presence of hydrophobic amino acids. As the temperature 
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increases, proteins begin to denature, exposing hidden hydrophobic residues, which interact 
with the dye and lead to an increase in fluorescence.66 The temperature at which a protein 
denatures is therefore determined as the point with the highest rate of increase in 
fluorescence. 
 
 
Figure 2.4: DSF trace of GspDAH7PSWT in the presence of 100 µM EDTA, where RFU is the relative 
fluorescence units. Shown in purple is the negative of the first derivative on the secondary axis. Tm is 
determined as the steepest part of the RFU trace and the minimum on the negative derivative. 
The Tm of the wild-type enzyme with no metal added (control) was determined to be 76.7 ± 
0.2 ᵒC. This value is very similar to the other Tm values obtained for the enzyme in the 
presence of a range of different divalent metal ions. A significantly lower Tm of 67.8 ± 0.3 ᵒC 
in the presence of 100 µM of EDTA was recorded. This difference in Tm in the presence of 
EDTA, compared to other conditions, suggests that there are traces of metal present in the 
protein preparation that are having a stabilising effect on the enzyme. This is further 
supported by the metal activation study on GspDAH7PSWT, which showed that enzyme was 
still active without metal additives and almost completely deactivated in the presence of 
EDTA, suggesting metal presence in the protein preparation (section 2.5). This would explain 
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the Tm value obtained for the control, as EDTA is a chelator that removes metal ions from 
the enzyme. The presence of the metals Cd2+ and Zn2+ causes two distinct rises in 
florescence, which are consistent with the wild-type enzyme having a two stage 
denaturation response to the increase in temperature, (Figure 2.5) with initial Tm values of 
53.1 ± 0.3 ᵒC and 42.5 ± 0.4 ᵒC respectively and secondary Tm values of 78.4 ± 0.7 ᵒC and 
81.9 ± 0.7 ᵒC respectively. The initial Tm values suggest that both metals are destabilising, 
while the secondary Tm values suggest that they are stabilising to the enzyme in comparison 
to the Tm value obtained in the presence of EDTA
 (Figure 2.6). The two-stage denaturation 
response appears to occur with GspDAH7PSWT in the presence of other metal ion additives 
as well, however, the peak for the second rise in fluorescence seems to be masked by the 
first peak (Figure 2.4). 
 
 
Figure 2.5: DSF trace of GspDAH7PSWT in the presence of 100 µM Cd2+ (purple and green lines) and 
100 µM Zn2+ where RFU is the relative fluorescence units. The negative of the first derivative on the 
secondary axis is shown in purple for Cd2+ and in orange for Zn2+. Tm is determined as the steepest 
part of the RFU trace and the minimum on the negative derivative. 
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Figure 2.6:  DSF data showing Tm of GspDAH7PS
WT in the presence of different conditions (no metal-
control, EDTA, Co2+, Cd2+, Zn2+, Mg2+, Ni2+, Pb2+, Ca2+, CA and PA at 100 µM with light blue bars 
indicating the secondary Tm for the enzyme. 
 
All of the conditions with added metal ions had a stabilising effect on the wild-type enzyme, 
with Tm values higher than that in the presence of EDTA. Pb
2+ was the least stabilising metal 
ion to the wild-type enzyme with a Tm of 71.9 ± 0.1 ᵒC (Figure 2.6). In the conditions with 
100 µM PA or CA present, there was a slight destabilising effect on GspDAH7PSWT in 
comparison to the no metal added (control) condition with a Tm of 72.7 ± 0.1 ᵒC and 72 ± 0.3 
ᵒC respectively. 
 
2.5 Metal activation 
All DAH7PS enzymes characterised to date have been shown to be dependent on a divalent 
metal ion for activity.67 A metal activation study was carried out in order to determine if the 
activity of GspDAH7PSWT is metal dependent, and if so, which metal is most activating for 
enzymatic activity. Buffer and substrate solutions used in metal activation studies were 
treated with Chelex® (an ion-exchange resin that removes polyvalent metal ions). A range of 
metal ions was used, along with metal chelators for the study. Cd2+ was found to be the 
most activating by a significant margin, whereas Zn2+ was least activating (Figure 2.7). 
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Figure 2.7: Metal activation of GspDAH7PSWT representing the different activation abilities of 
different metals in comparison to Cd2+ at a concentration of 100 µM. Also shown is the degree of 
inactivation of the wild-type enzyme in the presence of the metal chelators EDTA and DPA at a 
concentration of 100 µM.  Reactions were carried out at 60 ᵒC, with 195 µM PEP and 197 µM E4P in 
50 mM BTP buffer (pH 6.8). 
 
It was demonstrated that the enzyme was still active without any additives (control), 
suggesting metal presence in the protein preparation, consistent with the observations of 
the DSF study (section 2.4). The metal chelator dipicolinic acid (DPA) at 100 µM did not 
deactivate GspDAH7PSWT as the enzyme had very similar activity to the control condition (no 
additives). In the presence of chelator EDTA, at a concentration of 100 µM, the enzyme only 
demonstrated 3 % of the activity that was observed in the presence of Cd2+. 
This study confirms that GspDAH7PSWT is dependent on a metal ion for activation like all 
other characterised DAH7PS enzymes. The enzyme demonstrated very little activity in the 
presence of EDTA with a clear preference for Cd2+, which was most activating of the metal 
ions tested. While there has been no connection made with the type of DAH7PS enzyme 
and their metal preference, it is interesting to note that another type Iβ DAH7PS enzyme 
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fused to a CM domain isolated from the Bacillus genus, BsuDAH7PS, is also most activated 
by Cd2+.13 
 
2.6 Temperature dependency study 
Geobacillus sp is a thermophile that thrives at temperatures as high as 70 ᵒC.64 To determine 
the optimal temperature for GspDAH7PSWT activity, a temperature dependency study was 
carried out using a continuous spectrophotometric assay following the loss of PEP at 232 
nm.40 Substrates (PEP and E4P), metal (Cd2+), buffer (50 mM BTP, pH adjusted to the 
required temperature) and enzyme concentrations were kept constant while varying the 
temperature of the reaction mixture. Once the reaction mixture in the cuvette had 
equilibrated to the required temperature, enzyme was added and incubated for one minute 
before initiation of the reaction with E4P. The experiment was later repeated with the 
enzyme incubated for longer period of five minutes, to determine the effects of a longer 
incubation time (Figure 2.8).  It has been determined that the substrate E4P is unstable at 
elevated temperatures, with less than half of the E4P concentration (64 µM) remaining after 
30 minutes incubation at 60 ᵒC.40 Therefore it was important to initiate the reactions with 
E4P to minimise substrate loss, especially for the assays carried out at temperatures 
exceeding 60 ᵒC. 
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Figure 2.8: Temperature dependency of GspDAH7PSWT showing enzyme activity at different 
temperatures. Substrate (325 µM PEP, 475 µM E4P), metal (100 µM Cd2+), buffer (50mM BTP, pH 
6.8) and enzyme (5 µL at 0.2 mg/mL) concentrations were kept constant. Enzyme was incubated at 
desired temperature with the reaction mixture for either one minute (shown in dark blue) or five 
minutes (shown in light blue) 
 
GspDAH7PSWT is most active at 70 ᵒC and least active at 30 ᵒC under the given conditions. 
Activity increases as temperature increases, up to 70 ᵒC, and then drops slightly at 80 ᵒC. 
This result can be explained in the context of the DSF data for the wild-type enzyme, which 
had a Tm value of 78.4 ± 0.7 in the presence of Cd
2+ (section 2.4). At 80 ᵒC, the enzyme is 
likely to be denaturing, and a reduction in enzymatic activity is observed. While 
GspDAH7PSWT did have an initial Tm of 53.1 ± 0.3 ᵒC in the presence of Cd
2+, according to the 
DSF data, enzyme activity did not appear to be affected at 60 ᵒC. This would suggest that at 
60 ᵒC, the catalytic domain of the wild-type enzyme is still fully functional and not 
denaturing as no decrease in DAH7PS activity is observed.  Incubation of the enzyme with 
the reaction mixture for either one or five minutes did not appear to have an effect on the 
activity of the enzyme, although the activities at the elevated temperatures were slightly 
lower, consistent with the denaturation of the enzyme (Figure 2.8). 
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2.7 Temperature dependency study (chorismate mutase activity) 
Preliminary activity assays determined that GspDAH7PSWT also had CM activity, consistent 
with the prediction of a CM fusion protein based on sequence analysis. Another 
temperature dependency study was carried out on GspDAH7PSWT for CM activity. A 
continuous spectrophotometric assay following the loss of CA at 274 nm was used, where 
the substrate CA, buffer (pH adjusted for experimental temperatures) and enzyme 
concentrations were kept constant, while only varying the temperature (30 °C, 40 °C, 50 °C, 
60 °C, 70 °C and 80 °C). Once the reaction mixture in the cuvette had equilibrated to the 
required temperature, enzyme was added to the mixture and incubated for one minute 
before initiation of the reaction with CA. The experiment was later repeated with the 
enzyme incubated for longer period of five minutes, to determine the effects of a longer 
incubation time (Figure 2.9). 
 
Figure 2.9: Temperature dependency of GspDAH7PSWT showing CM activity at different 
temperatures (30 °C, 40 °C, 50 °C, 60 °C, 70 °C and 80 °C) without the addition of any metal ions. 
Substrate (70 µM CA) buffer (50 mM BTP, pH 6.8) and enzyme (3 µL at 13 mg/mL) concentrations 
were kept constant. Enzyme was incubated at desired temperature with the reaction mixture for 
either one minute (shown in dark blue) or five minutes (shown in light blue).  
 
The results show that GspDAH7PSWT CM enzyme activity increases as temperature 
increases. The wild-type enzyme is most active at 70 ᵒC, and then activity drops sharply at 
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80 ᵒC. This is consistent with the wild-type DAH7PS enzymatic activity that also drops at 80 
ᵒC (section 2.6). Incubating the wild-type enzyme with the reaction mixture for either one or 
five minutes did not make an appreciable difference to the data (Figure 2.9). 
 
2.8 Michaelis-Menten kinetics 
2.8.1 DAH7PS activity 
Once the most activating metal ion (section 2.5) and temperature (section 2.6) were 
determined for GspDAH7PSWT, the results were incorporated in the experimental procedure 
to obtain the steady state kinetic parameters of the enzyme. The steady state kinetic 
parameters were measured by monitoring the consumption of PEP at 232 nm (Figure 2.10). 
The continuous spectrophotometric assay for the enzyme was carried out at 60 ᵒC, despite 
this being lower than the temperature GspDAH7PSWT is most active at (section 2.6), this 
ensured sufficient time for accurate rates to be recorded in vitro without the degradation of 
E4P, used to initiate the continuous assay, due to its instability at elevated temperatures.1 
The use of a continuous assay (previously used in the characterisation of TmaDAH7PS68 and 
PfuDAH7PS40) instead of a discontinuous assay, is a more convenient method that gives 
more accurate data, as more data points can be obtained.40 Other studies characterising 
type Iβ DAH7PS enzymes such as BsuDAH7PS,13 PgiDAH7PS12 and ApeDAH7PS15 used a 
discontinuous colourimetric or Aminoff periodate-thiobarbituric acid assay system, or a 
combination of both continuous and discontinuous methods. 
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Figure 2.10: Michaelis-Menten plots obtained for GspDAH7PSWT showing the apparent PEP (left) Km 
value of 87 ± 9 µM and E4P (right) Km with a value of 95 ± 8 µM. A kcat value of 45 ± 4 s
-1 was 
obtained. Standard assays were carried out at 60 °C in 50 mM BTP buffer (pH 6.8) and 100 µM Cd2+. 
 
Initial velocities for the catalytic activity of GspDAH7PSWT were determined by keeping the 
concentration of one substrate fixed (PEP concentration was fixed at 338 µM and E4P 
concentration was fixed at 329 µM) while varying the concentration of the other substrate. 
The apparent Km values for PEP and E4P were found to be 87 ± 9 µM and 95 ± 8 µM 
respectively, with a calculated kcat value of 45 ± 4 s
-1 ( 
Table 2.1).  Due to the difference in temperatures and assay conditions used to obtain 
kinetic parameters of other type Iβ DAH7PS enzymes, it is difficult to make accurate 
comparisons of the data obtained. It is noted however that GspDAH7PSWT does have a larger 
kcat value in comparison to the other type Iβ DAH7PS enzymes. 
 
Table 2.1: Kinetic parameters for GspDAH7PSWT and other type Iβ DAH7PS enzymes 
Enzyme Km
PEP (µM) Km
E4P (µM) kcat (s
-1) kcat/Km
PEP(µM.s-1) kcat/Km
E4P(µM.s-1) 
GspDAH7PSWT  87 ± 9 
 
95 ± 8 
 
45 ± 4 0.52 0.47 
BsuDAH7PS13 139 ± 11.4 1760 ± 110 4.6 ± 0.1 3.3 x 10-2 2.6 x 10-3 
PgiDAH7PS12 421 ± 43 1238 ± 141 1.6 ± 0.1 3.8 x 10-3 1.3 x 10-3 
TmaDAH7PS68 4.9 ± 0.4 13 ± 1 11.7 ± 0.2 2.4  0.9  
PfuDAH7PS40 120 ± 20 28 ± 4 1.5 ± 0.1 1.3 x 10-2 5.4 x 10-2 
ApeDAH7PS15 890 ± 30 280 ± 20 1.0 ± 0.2 1.1 x 10-3 3.6 x 10-3 
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2.8.2 Chorismate mutase activity 
The steady state kinetic parameters for the CM activity of GspDAH7PSWT were measured by 
tracking the consumption of CA at 274 nm (Figure 2.11). While the temperature dependency 
study for GspDAH7PSWT showed that the enzyme’s enzymatic activity was highest at 70 ᵒC 
(Section 2.7), assays were carried out at 50 ᵒC. This was to ensure that CA would not 
degrade while carrying out the experiment, as it is a highly unstable compound, especially at 
elevated temperatures.  
 
 
 
Figure 2.11: Michaelis-Menten plot obtained for GspDAH7PSWT showing the apparent CA Km with a 
value of 88 ± 6 µM and a kcat value of 1.9 ± 0.13 s
-1. Standard assays were carried out at 50 °C in 50 
mM BTP buffer (pH 6.8) without the addition of any metal ions. 
 
Initial velocities for the catalytic CM activity were measured by initiating the equilibrated 
reaction mixture with varying concentrations of CA. The apparent Km value for CA was 88 ± 6 
µM for with a calculated kcat value of 1.9 ± 0.13 s
-1 (Table 2.2). In comparison to BsuDAH7PS, 
GspDAH7PSWT displays a much more active CM domain with a higher affinity for CA (Table 
2.2). 
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Table 2.2: Kinetic parameters for CM activity of GspDAH7PSWT and other DAH7PS enzymes 
Enzyme Km
CA (µM) kcat (s
-1) kcat/Km
 CA (µM.s-1) 
GspDAH7PSWT  88 ± 6 
 
1.9 ± 0.13   2.1x10-2 
 
BsuDAH7PS13 851 ± 97 0.41 ± 0.01 4.8x10-4 
PgiDAH7PS12 Not active ……. ……. 
MtuCM+MtuDAH7PS63 34 ±3 8.1 ± 1.9 0.24 
EcoDAH7PS69 30 ± 1  
 
41.4 ± 0.4  
 
1.4  
 
 
 
2.9 Inhibition
 
Characterisation studies have shown that some DAH7PS enzymes have evolved extensions 
to the core (β/α)8 barrel that are involved in feedback regulation. 
16,46,48,49 Previously 
characterised DAH7PS enzymes fused to an allosteric CM domain demonstrated inhibition 
of the DAH7PS activity in the presence of CA or PA.12 These results led to the hypothesis that 
GspDAH7PSWT may also be inhibited in the presence of the branch point intermediates, CA 
or PA, due to the presence of an N-terminal CM domain extension. 
An inhibition study was carried out on GspDAH7PSWT in the presence of PA to determine if 
this compound would inhibit the enzyme. DAH7PS activity was tested using the same 
Method as above (section 2.8.1). Substrate (PEP, E4P), metal (Cd2+), and enzyme 
concentrations were kept constant in 50 mM BTP buffer (pH 6.8), while the concentration of 
PA was varied. PA, rather than CA, was the inhibitor chosen since CA is unstable at elevated 
temperatures. CA is also converted to PA via CM almost instantaneously, which would be 
occurring while the experiment is being carried out, leading to lack of clarity about the 
inhibitory species in the assay. Furthermore, it has been previously suggested in a study on 
BsuDAH7PS, that PA is the true inhibitor of the DAH7PS domain instead of CM in vivo.12 This 
was due to a sigmoid inhibition curve being obtained for BsuDAH7PS in the presence of 
increasing concentrations of CA. It is believed that CA was being converted to PA initially, 
which in turn inhibited BsuDAH7PS activity. 
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Figure 2.12: Response of GspDAH7PSWT activity to increasing concentrations of PA. Standard assays 
were carried out at 60 ᵒC, with 121 µM PEP and 123 µM E4P in 50 mM BTP buffer (pH 6.8). The data 
points were measured in triplicate with error bars indicating the standard deviation. 
 
The results clearly demonstrate that PA inhibits GspDAH7PSWT (Figure 2.12). A logistic 
function fitted to the data gives an IC50 value of 25.3 µM.  This result shows increased 
sensitivity to PA in comparison to BsuDAH7PS (IC50 value of 100 µM), but significantly less 
sensitivity to PA in comparison to PgiDAH7PS, where the CM domain is fused to the C-
terminal of the DAH7PS barrel (IC50 value of 1.5 µM) (Table 2.3).  
 
Table 2.3:  Estimated IC50 values of GspDAH7PSWT, BsuDAH7PS and PgiDAH7PS 
Enzyme Estimated IC50 (µM) 
 Prephenate Chorismate 
GspDAH7PSWT 25.3 not determined 
BsuDAH7PS12 100 1000 
PgiDAH7PS12 1.5 2.5 
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2.10 Analytical ultracentrifugation of GspDAH7PS
WT
 
Gel filtration traces of GspDAH7PSWT showed that the enzyme eluted as a single peak 
containing a shoulder. SDS-PAGE analysis along with activity assays determined that both 
the peak and the shoulder contained GspDAH7PSWT. This suggested that the wild-type 
enzyme might be in equilibrium between two different oligomeric states in solution. 
 
 
 
 
Figure 2.13: Sedimentation velocity analysis of GspDAH7PSWT at 1.8 mg/ml (blue line), 1 mg/ml (red 
line) and 0.5 mg/ml (black line); all curves were normalised to 1. Experiments were carried in SEC 
buffer (pH 7.4 at 20 ᵒC). Data was collected at 50,000 rpm at a wavelength of 280 nm. (A) the best fit 
and residuals of the experimental data. (B) the distribution of the species. 
(a) 
(b) 
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An investigation into the quaternary assembly of GspDAH7PSWT in solution was carried out 
using analytical ultracentrifugation (AUC) (Figure 2.13). By applying extreme gravitational 
forces on an enzyme of interest, and tracking its sedimentation behaviour, this technique 
helps to determine if the enzyme exists as one or multiple species in solution. The technique 
also helps to determine whether quaternary structure of the enzyme is concentration 
dependent.  
 
Stock solutions of wild-type enzyme were buffer exchanged into freshly made SEC buffer (10 
mM BTP, pH 7.4, 40 mM KCl, 200 µM PEP and 10 µM EDTA) and made up to three different 
concentrations (1.8 mg/mL, 1 mg/mL and 0.5 mg/mL). In an ultracentrifuge, each sample 
was run simultaneously with a blank containing an exact buffer match to ensure a precise 
profile of the enzyme in solution was obtained. 
 
According to the absorbance versus radial position data, two sedimentation boundaries 
exist for GspDAH7PSWT, suggesting that the enzyme exists as two oligomeric species in 
solution. A best fit of the experimental data showed the presence of two species that had 
sedimentation coefficients of 4.9 S and 7.3 S. Fitting the sedimentation velocity data, 
correlated to calculated masses of 80 kDa and 145 kDa for GspDAH7PSWT. This is consistent 
with the molecular masses for the dimeric (83 kDa) and tetrameric (165 kDa) assemblies of 
GspDAH7PSWT. 
 
To ensure that equilibrium between two oligomeric states was being observed, 
sedimentation equilibrium experiments at different concentrations were carried out. 
Normalising the tetrameric sedimentation coefficient boundaries obtained to 1 for all 
concentrations showed that as the concentration of enzyme increased, tetramer formation 
was favoured with a reduced dimer formation. 
 
CA is converted to PA in the shikimate pathway, a reaction mediated by CM. PA has been 
shown to completely inhibit the DAH7PS domain of the wild-type enzyme, and this is likely 
to arise from it binding to the CM domain (section 2.9). 
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The same experiment as above was carried out with the wild-type enzyme in the presence 
of PA, in attempt to find any effects of the inhibitor on the dimer tetramer equilibrium. Such 
information could give key information on the mechanism for inhibition of GspDAH7PSWT by 
PA. In this experiment, a sample was run at a concentration of 1 mg/ml in the presence of 
500 µM PA (Figure 2.14). Data obtained was compared with the AUC data for GspDAH7PSWT 
in the absence of PA at a concentration of 1 mg/ml. 
  
 
 
 
Figure 2.14: Sedimentation velocity analysis of GspDAH7PSWT at a concentration of 1 mg/ml in the 
presence of 500 µM PA (blue line), and in the absence of PA (red line). Experiments were carried in 
SEC buffer (pH 7.4 at 20 ᵒC). Data was collected at 50,000 rpm at a wavelength of 280 nm. (a) the 
best fit of the experimental data. (b) the distribution of the species. 
(a) 
(b) 
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Absorbance versus radial position data showed the existence of two sedimentation 
boundaries for the wild-type enzyme in the presence of PA, suggesting that the enzyme still 
exists as two oligomeric species in solution. A best fit of the experimental data showed the 
presence of two species that had sedimentation coefficients of 4.5 S and 7.8 S. Fitting the 
sedimentation velocity data, correlated to calculated masses of 80 kDa and 170 kDa for 
GspDAH7PSWT. This is consistent with the molecular masses for the dimer (83 kDa) and 
tetramer (165 kDa) of GspDAH7PSWT. 
 
Comparison of the sedimentation velocity data in the presence and absence of PA by 
normalising the tetrameric sedimentation boundaries to 1, showed that addition of PA lead 
to a dramatic increase in tetramer formation and a reduction in dimer. PA binding to the 
regulatory CM domain leads to the formation of a more stable quaternary enzyme where 
CM domains from diagonally opposite sides of the tetramer interlock with one another to 
hold the tetrameric structure together. 
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2.11 Summary  
GspDAH7PSWT was expressed and purified successfully by heat treatment, metal-affinity and 
size exclusion chromatography. Mass spectrometry determined that the enzyme was of the 
expected mass. The enzyme was found to be thermally stable and demonstrated both CM 
and DAH7PS activity. 
DSF results showed that different metal ions had different stabilising effects on 
GspDAH7PSWT in comparison to EDTA, which was destabilising to the enzyme. The 
substrates PA and CA were also destabilising to the enzyme. 
GspDAH7PSWT was determined to be affected by temperature and to be metal dependent, 
with the highest CM and DAH7PS enzymatic activity’s demonstrated at 70 ᵒC, and with Cd2+ 
being the most activating metal ion for the enzyme. 
Kinetic assays revealed the Michaelis-Menten kinetics of the wild-type enzyme for both the 
CM and DAH7PS domain activity’s. The DAH7PS domain had apparent Km values of 87 ± 9 
µM and 95 ± 8 µM for PEP and E4P respectively, with a calculated kcat value of 45 ± 4 s
-1, a 
value higher than has been reported for other characterised type Iβ DAH7PS enzymes. The 
CM domain had an apparent Km value of 88 ± 6 µM for CA with a calculated kcat value of 1.9 
± 0.1 s-1. 
 
AUC determined that GspDAH7PSWT exists in equilibrium between a dimeric and tetrameric 
state with the equilibrium shifting toward tetramer formation with increasing enzyme 
concentration. PA, which was found to completely inhibit DAH7PS activity, led to a dramatic 
increase in tetramer formation and a decrease in dimer formation. 
 
Based on previous studies of type Iβ and other regulated DAH7PS enzymes12,16 it is 
suggested that the N-terminal CM of GspDAH7PSWT is for allosteric regulation. To determine 
if this is really the case, further work was needed. The next step was to carry out a domain 
truncation on GspDAH7PSWT by separating the catalytic and putative regulatory domains in 
order to characterise them independently. This would help determine if the CM domain is 
essential for enzyme regulation. 
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3.Chapter 3 
 
Expression and biochemical characterisation 
of truncated Geobacillus sp CM and DAH7PS 
 
3.1 Overview 
Previous studies of DAH7PS enzymes over the years have shown that all DAH7PS enzymes 
from different organisms share the same catalytic core (β/α)8  barrel fold.
16 Some of these 
enzymes were found to be regulated, containing different small domain extensions fused to 
the core barrel, and these proteins are believed to have evolved from an undecorated and 
unregulated ancestral DAH7PS enzyme.20 Amongst the type Iβ DAH7PS subfamily are 
enzymes that consist of only the (β/α)8 barrel such as PfuDAH7PS
40 and ApeDAH7PS,15 both 
of which have no known regulators or natural inhibitors. These enzymes differ from others 
in the type Iβ DAH7PS subfamily such as BsuDAH7PS,13 PgiDAH7PS12 and TmaDAH7PS,68 
which contain extensions to the catalytic barrel and are regulated. It has been suggested 
that these extensions were incorporated for the sole purpose of feedback regulation, where 
the activity of the catalytic DAH7PS domain is regulated through pathway intermediates or 
end products binding to the extensions. Type Iβ DAH7PS enzymes are the most widely 
distributed in nature and are therefore believed to be most closely related to the common 
ancestral DAH7PS enzyme, making them a great deal of importance in determining the 
evolution pattern of the DAH7PS family.19 
 
GspDAH7PSWT is a type Iβ DAH7PS enzyme containing an N-terminal CM domain, believed to 
have evolved for the sole purpose of regulation of catalytic barrel, and while it has shown 
that this enzyme is regulated by the pathway intermediate PA, further investigation is 
needed to determine this.  In this chapter, a domain truncation was carried out on the wild-
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type enzyme leading to independent expression and purification of the DAH7PS and CM 
domains. Each domain was characterised in a similar manner to GspDAH7PSWT, and 
comparative studies were carried out between the wild-type enzyme and the truncated 
variants to help determine the effects of this.  
 
3.2 Truncation site 
GspDAH7PSWT was truncated between residues Lys92 and Ala93 located at the linker region 
connecting the DAH7PS domain and the CM domain. Previous domain truncation 
studies,12,16 structural and sequence comparisons with PfuDAH7PS and LmoDAH7PS (Figure 
3.1) helped to determine the linker region, and a truncation at this position appeared to be 
the best choice as it is most likely to lead to separate and intact DAH7PS domain. It should 
be noted that although the initial analysis was carried out prior to the availability of the 
crystal structure of this protein, the structure confirmed the linker position (Figure 3.2). 
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GspDAH7PS       MGNERLDELRARVDEINLQLLKLINERGRLVQEIGKIKEAQGTHRYDPVRERKMLDLISE 60 
LmoDAH7PS       MVNTNLEELRTQVDQLNIDLLELISKRANLVQEIGKIKGTQGSLRFDPLREREMLNTILA 60 
PfuDAH7PS       ------------------------------------------------------------ 
                                                                             
 
GspDAH7PS       HNDGPFETSTLQHIFKEIFKAALELQEDDHRKALLVSRKKHPENTIVEVKGERIGDGNQY 120 
LmoDAH7PS       ANEGPFEDSTVQKLFKEIFKAGLELQEEDHSKALLVSRKNKKEDTIVTVKGLPIGNGEPV 120 
PfuDAH7PS       ----------------------------------MKYSKEYKEKTVVKINDVKFGEG-FT 25 
                                                  :   *:  *.*:* ::.  :*:*    
 
GspDAH7PS       FVMGPCAVESYEQVAAVAEAVKKQGIKLLRGGAYKPRTSPYDFQGLGVEGLKILKRIADE 180 
LmoDAH7PS       FVFGPCSVESYEQVAAVAESIKAKGLKLIRGGAFKPRTSPYDFQGLGLEGLKILKRVSDE 180 
PfuDAH7PS       IIAGPCSIESRDQIMKVAEFLAEVGIKVLRGGAFKPRTSPYSFQGYGEKALRWMREAADE 85 
                :: ***::** :*:  *** :   *:*::****:*******.*** * :.*: ::. :** 
 
GspDAH7PS       FDLAVISEIVTPADIEIALDYIDVIQIGARNMQNFELLKAAGQVNKPILLKRGLAATIEE 240 
LmoDAH7PS       YGLGVISEIVTPADIEVALDYVDVIQIGARNMQNFELLKAAGRVDKPILLKRGLSATIEE 240 
PfuDAH7PS       YGLVTVTEVMDTRHVELVAKYSDILQIGARNSQNFELLKEVGKVENPVLLKRGMGNTIQE 145 
                :.* .::*:: . .:*:. .* *::****** ******* .*:*::*:*****:. **:* 
 
GspDAH7PS       FINAAEYIMSQGNGQIILCERGIRTYERATRNTLDISAVPILKKETHLPVFVDVTHSTGR 300 
LmoDAH7PS       FIGAAEYIMSQGNGKIILCERGIRTYEKATRNTLDISAVPILKKETHLPVMVDVTHSTGR 300 
PfuDAH7PS       LLYSAEYIMAQGNENVILCERGIRTFETATRFTLDISAVPVVKELSHLPIIVDPSHPAGR 205 
                :: :*****:*** ::*********:* *** ********::*: :***::** :*.:** 
 
GspDAH7PS       RDLLIPCAKAALAIGADGVMAEVHPDPAVALSDSAQQMDIAQFNEFMEEVRAFQRQFVRA 360 
LmoDAH7PS       KDLLLPCAKAALAIEADGVMAEVHPDPAVALSDSAQQMDIPEFEEFWNAILASN-LVPHK 359 
PfuDAH7PS       RSLVIPLAKAAYAIGADGIMVEVHPEPEKALSDSQQQLTFDDFLQLLKELEALGWKG--- 262 
                :.*::* **** ** ***:*.****:*  ***** **: : :* :: : : *         
 
GspDAH7PS       LE 362 
LmoDAH7PS       IK 361 
PfuDAH7PS       -- 
 
    * Conserved residues 
    : Conserved substitutes 
    . Semi-conservative substitutes 
 
 
 
Figure 3.1: ClustalW sequence alignment of GspDAH7PSWT, LmoDAH7PS and PfuDAH7PS which 
consists of only a catalytic DAH7PS domain. The linker residues connecting the N-terminal CM 
domain and the DAH7PS domain of LmoDAH7PS are highlighted in yellow. The truncation site of 
GspDAH7PSWT is highlighted in yellow. The CM and DAH7PS truncated mutant sequences of 
GspDAH7PSWT are shown in green and red respectively. 
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Figure 3.2: Structural comparison of GspDAH7PSWT and PfuDAH7PS (PDB code 1ZCO) subunits 
showing the truncation site of GspDAH7PSWT. The GspDAH7PSWT monomer is shown in red to 
represent the catalytic DAH7PS domain and green to represent the regulatory N-terminal CM 
domain. The grey dotted line represents the missing linker region (not observable due to high 
flexibility of the linker) connecting both domains of the GspDAH7PSWT monomer.  The PfuDAH7PS 
monomer is shown in dark blue to represent the DAH7PS domain. 
 
The genes corresponding to the ORFs for both GspDAH7PSDAH7PS (not including the sequence 
encoding the non-cleavable C-terminal tag) and GspDAH7PSCM were amplified from the 
plasmid, which contained the gene for  GspDAH7PSWT using primers and a two-round nested 
PCR protocol (experimental Section 5.3.1) (Figure 3.3).  
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Figure 3.3: Agarose gels showing round 2 nested PCR gene products coding for (a) GspDAH7PSDAH7PS 
and (b) GspDAH7PSCM in lane 1 of each gel. 
 
3.3 Cloning and expression of GspDAH7PS
DAH7PS 
Once amplified, the gene encoding for GspDAH7PSDAH7PS was ligated into the entry vector 
pDONR221 using a recombination reaction catalysed by BP clonase. DNA sequencing 
confirmed that the gene of interest with the correct sequence had been inserted. The gene 
coding for GspDAH7PSDAH7PS was then transferred to the destination vector pDEST17 using a 
further recombination reaction catalysed by LR clonase. This vector allows the desired 
protein to be expressed with a hexaHis-tag at the N-terminal, making it easy to detect and 
purify. The tag includes a Tobacco Etch Virus (TEV) protease cleavage site that allows for the 
removal of the tag using TEV protease following protein purification. 
 
The pDEST17 vector containing the gene for His-GspDAH7PSDAH7PS was transformed into E. 
coli chaperone 3 cells. Cells were grown and protein expression was induced by the addition 
of IPTG. The cells were harvested from the growth media by centrifugation, resuspended in 
HisTrap HP binding buffer (20 mM sodium phosphate, 0.5 M NaCl, 20 mM imidazole, pH 
7.4), lysed, heat treated at 55˚C for 30 minutes and left to cool to room temperature. The 
(a)
  
(b) 
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soluble protein of interest was separated from the insoluble material and cell debris by 
centrifugation. SDS-PAGE analysis of the cells before and after induction, and the 
supernatant after lysis and centrifugation showed that His-GspDAH7PSDAH7PS was 
overexpressed at the predicted molecular weight  (approximately 31 kDa) with most of the 
protein being present in the supernatant (Figure 3.4). A basic activity assay confirmed that 
the supernatant had DAH7PS activity. 
 
 
 
Figure 3.4: SDS-PAGE analysis for His-GspDAH7PSDAH7PS before induction (lane 1), after induction 
(lane 2), after lysis and heat treatment (lane 3), and in the supernatant after centrifugation (lane 4). 
 
3.4 Purification of GspDAH7PS
DAH7PS
 variant 
His-GspDAH7PSDAH7PS was further purified using nickel ion affinity chromatography. 
Following binding of the protein in low concentration imidazole buffer (20 mM), the protein 
was eluted with a high concentration of imidazole using a linear gradient elution. SDS-PAGE 
analysis helped to determine the eluted fractions containing protein of interest, which were 
pooled, concentrated and put down a desalting column to reduce the high imidazole 
concentration (Figure 3.5). TEV protease was added to cleave the His-tag from the protein, 
57 
 
and left overnight at 4 °C. The protein and His-tag mixture were then passed through a 
nickel ion affinity column another time to separate the His-tag from the untagged 
GspDAH7PSDAH7PS, which was eluted in the unbound fractions (Figure 3.5). Fractions 
containing GspDAH7PSDAH7PS were pooled, concentrated and further purified using size 
exclusion chromatography (SEC). GspDAH7PSDAH7PS was found to elute in two peaks from the 
SEC column (Figure 3.6). 
 
 
Figure 3.5: SDS-PAGE analysis for GspDAH7PSDAH7PS after first nickel ion affinity column (lane 1), after 
desalting column (lane 2), after TEV cleavage (lane 3) and after second nickel ion affinity column  
(lane 4). 
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Figure 3.6: SEC trace of eluted GspDAH7PSDAH7PS in SEC buffer (10 mM BTP, pH 7.4, 40 mM KCl, 200 
µM PEP and 10 µM EDTA) showing both peaks corresponding to the eluted protein. The numbers 1 
to 4 represent the lane number on the SDS-PAGE gel of where the fractions from the SEC run were 
taken (Figure 3.7). 
 
SDS-PAGE analysis showed that both peaks contained protein of the right molecular mass, 
with protein from each peak containing DAH7PS activity according to an enzyme activity 
assay (Figure 3.7). Fractions from each peak were pooled separately, concentrated, put into 
aliquots, and stored at -80 ᵒC 
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Figure 3.7: SDS-PAGE gel of final collected fractions after SEC of GspDAH7PSDAH7PS. Lanes 1 and 2 
showing fractions collected from the first peak.  Lanes 3 and 4 showing fractions collected from the 
second peak (Figure 3.6) 
 
The presence of two peaks on the SEC trace along with enzyme from each peak being active 
and of the correct molecular weight, suggested that GspDAH7PSDAH7PS is present in two 
oligomeric states in solution. Further experimental tests were needed to confirm this. 
 
3.5 Cloning and expression of GspDAH7PS
CM
  
The gene coding for GspDAH7PSCM was ligated into the entry vector pDONR221 using BP 
clonase. DNA sequencing was carried out to confirm that the gene of interest with the 
correct sequence had been inserted. The plasmid bearing the GspDAH7PSCM gene was 
initially recombined with the destination vector pDEST 17 using an LR clonase catalysed 
reaction, to add an N-terminal hexaHis-tag. Attempts were made to purify the enzyme, and 
while there was expression, the enzyme showed no signs of solubility. A different 
destination vector had to be used to aid in the solubility of GspDAH7PSCM. 
 
The plasmid bearing the GspDAH7PSCM gene was then recombined with the destination 
vector pDEST15, allowing the desired protein to be expressed with an N-terminal GST-tag 
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that is cleavable with TEV protease. The GST protein aids with solubility of the desired 
protein and helps deliver higher protein yields.  This plasmid was transformed into E. coli 
One Shot BL21 star (DE3) cells (Life Technologies) for expression.  
 
Cells bearing the plasmid encoding the GST-GspDAH7PSCM gene were grown and protein 
expression was induced. The cells were harvested, resuspended in GSTrap binding buffer 
PBS, (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4 pH 7.3) and then lysed 
before being centrifuged in order to separate the soluble protein of interest from the 
remaining lysed cells. SDS-PAGE analysis of the whole cells before and after induction, along 
with the supernatant showed that GST-GspDAH7PSCM was overexpressed at the predicted 
molecular weight (approximately 36 kDa) with most of the protein being present in the 
supernatant (Figure 3.8). An activity assay indicated that there was CM activity in the 
supernatant. 
 
 
Figure 3.8: SDS-PAGE analysis for GST-GspDAH7PSCM before induction (lane 1), after induction (lane 
2), whole cell before centrifugation (lane 3), and in the supernatant after centrifugation (lane 4). 
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3.6 Purification of GspDAH7PS
CM
 variant 
The collected supernatant was applied to a GSTrap affinity column. Column bound GST-
GspDAH7PSCM, was then eluted with a high concentration of glutathione using a linear 
gradient. Determined by SDS-PAGE analysis, eluted fractions containing GST-GspDAH7PSCM 
were then were then collected, concentrated and passed through a desalting column to 
remove the high glutathione content.  TEV protease was added to cleave and separate the 
GST-tag from the protein (Figure 3.9). The resulting supernatant was put down the GSTrap 
again to separate the GST-tag, which binds to the GSTrap column, from GspDAH7PSCM that 
was eluted in the non-bound fractions.  GspDAH7PSCM fractions were pooled, concentrated 
and further purified using SEC. GspDAH7PSCM was found to elute in three peaks off the SEC 
column along with a shoulder to the left of the second peak. (Figure 3.10) 
 
 
Figure 3.9: SDS-PAGE analysis for GspDAH7PSCM after first GSTrap affinity column (lane 1), after 
desalting column  (lane 2), after TEV cleavage (lane 3)  
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Figure 3.10: SEC trace of eluted GspDAH7PSCM in SEC buffer (10 mM BTP, pH 7.4, 40 mM KCl, 200 µM 
PEP and 10 µM EDTA) showing three peaks corresponding to the eluted protein with the shoulder to 
the left of the second peak. Numbers 1 to 9 represent the lane number on the SDS-PAGE gel of 
where the fractions from the SEC run were taken (Figure 3.11). 
 
SDS-PAGE analysis showed that only peaks two and three along with the shoulder contained 
GspDAH7PSCM, with both peaks being active as determined by an enzyme activity assay. 
Peak one did not appear to contain any GspDAH7PSCM and lacked CM activity (Figure 3.11). 
Peaks two and three were pooled separately avoiding peak 1 and the shoulder, 
concentrated down, put into aliquots, flash frozen and stored at -80 °C. 
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Figure 3.11: SDS-PAGE gel of final collected fractions after SEC of GspDAH7PSCM. Lanes 1-3 show 
fractions collected from the first peak.  Lanes 4-7 show fractions collected from the second peak. 
Lanes 8 and 9 show fractions collected from the third peak (Figure 3.10) 
 
3.7 Mass spectrometry 
The molecular masses of GspDAH7PSDAH7PS and GspDAH7PSCM were determined using 
electrospray ionisation mass spectrometry to ensure the purified enzymes were of the 
expected mass calculated from the amino acid sequence using ProtPram. GspDAH7PSDAH7PS 
had a mass of 30,095 Da and GspDAH7PSCM had a mass of 11,149 Da, which is in agreement 
with the calculated masses of 30,095 Da and 11,149 Da respectively. 
 
Once both variants were purified, different experiments were carried out in order to 
characterise each enzyme, the data obtained could then be used to compare to 
experimental data of the wild-type enzyme (Figure 3.12). 
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Figure 3.12: SDS-PAGE gel of purified GspDAH7PSWT (lane1), GspDAH7PSDAH7PS (Lane 2) and 
GspDAH7PSCM (Lane 3) after SEC. 
 
3.8 Protein secondary structure analysis 
Circular dichroism (CD) spectra were obtained for GspDAH7PSDAH7PS expected to comprise 
only the core barrel and GspDAH7PSCM, which was expected to be α-helical. CD is an initial 
method of ensuring that the enzymes had folded properly and that no major conformational 
changes to the core barrel or the CM domain in the absence of the other component had 
occurred (Figure 3.14). 
CD data for PfuDAH7PS65 was used to compare with the CD data obtained for 
GspDAH7PSDAH7PS since both enzymes consist of only the core barrel (Figure 3.13).  
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Figure 3.13: Circular dichroism spectra of GspDAH7PSDAH7PS (red) and PfuDAH7PS (dark blue). A 
protein concentration of 0.15 mg/mL for GspDAH7PSDAH7PS and 0.01 mg/mL for PfuDAH7PS was used 
exchanged into double-distilled water (pH 7.0). 
 
 
Figure 3.14: Circular dichroism spectra of GspDAH7PSDAH7PS (red) and GspDAH7PSCM (green). A 
protein concentration of 0.15 mg/mL was exchanged into double-distilled water (pH 7.0). 
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Although the CD spectrum of PfuDAH7PS was of a poor quality, it showed similarities to the 
CD spectrum of GspDAH7PSWT as anticipated. The trace for GspDAH7PSCM resembles the 
expected traces for a helical protein. This data suggests that GspDAH7PSDAH7PS and 
GspDAH7PSCM are properly folded and are suitable for further characterisation. 
 
3.9 Differential scanning fluorimetry for GspDAH7PS
DAH7PS
 and 
GspDAH7PS
CM
 
While DSF was carried out on GspDAH7PSWT, it was important to determine the thermal 
stabilities of the separated regulatory CM domain and the catalytic DAH7PS domain under 
the same conditions used for the wild-type enzyme. Comparison of the data obtained for 
both mutants with the wild-type enzyme would reveal any effects on both domains when 
separated. The thermal stabilities of both GspDAH7PSDAH7PS and GspDAH7PSCM were 
examined under different conditions (no metal-control, EDTA, Co2+, Cd2+, Zn2+, Mg2+, Ni2+, 
Pb2+, Ca2+, CA, PA) using DSF.  
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Figure 3.15: DSF data showing Tm of (a) GspDAH7PS
WT (blue), GspDAH7PSDAH7PS (red), (b) 
GspDAH7PSWT (blue) and GspDAH7PSCM  (green) in the presence of different conditions (no metal-
control), EDTA, Co2+, Cd2+, Zn2+, Mg2+, Ni2+, Pb2+, Ca2+, CA, PA) at 100 µM with light blue bars 
indicating the secondary Tm for GspDAH7PS
WT and light green bars indicating the secondary Tm for 
GspDAH7PSCM. 
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In the condition with no metal added (control) both GspDAH7PSDAH7PS and GspDAH7PSCM are 
less stable than the wild-type enzyme with melting temperatures recorded at 58.9 ± 0.1 ᵒC 
and 69 ± 0.2 ᵒC respectively, in comparison to the temperature of 76.7 ± 0.2 ᵒC observed for 
the wild-type enzyme. While the inclusion of EDTA has been shown to destabilise the wild-
type enzyme, EDTA had no effect on stability for either GspDAH7PSDAH7PS or GspDAH7PSCM 
with Tm values of 59.3 ± 0.3 ᵒC and 69.2 ± 0.2 ᵒC respectively (Figure 3.15). Mn
2+, Co2+, Cd2+, 
Zn2+ or Pb2+ were the only additives that stabilised GspDAH7PSDAH7PS, with Cd2+ and Zn2+ 
being the most stabilising, giving Tm values of 78.6 ± 0.5 ᵒC and 79.2 ± 0.2 ᵒC respectively.  
For the wild-type enzyme, the presence of either Cd2+ or Zn2+ brought about two distinct 
rises in florescence, consistent with a two stage thermal denaturation response. This two 
stage process was not evident for GspDAH7PSDAH7PS (Figure 3.15). Interestingly Cd2+ and Zn2+ 
were the only destabilising conditions for GspDAH7PSCM , with Zn2+ causing the variant to 
also have a two stage thermal denaturation response with at 50.7 ± 0.1 ᵒC for the first 
denaturation response, then 62.7 ± 0.1 ᵒC for the second denaturation response. All other 
conditions did not appear to have any effect on the stability of the enzyme (Figure 3.15). 
The results suggest that Cd2+ and Zn2+ have a destabilising effect on the CM domain, yet are 
stabilising to the DAH7PS domain of GspDAH7PSWT. This conclusion is supported by the fact 
that both metal ions are destabilising to GspDAH7PSCM but stabilising to GspDAH7PSDAH7PS. 
This would explain why the wild-type enzyme has a two stage thermal denaturation 
response to both metal ions. 
 
3.10 Metal activation of GspDAH7PS
DAH7PS 
A metal activation study carried out on GspDAH7PSWT determined that the enzyme was 
most activated by Cd2+ (section 2.5). The same study was carried out for GspDAH7PSDAH7PS in 
order to determine if the removal of the CM domain had any effect on the enzyme’s ability 
to be activated by different metals.  
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Figure 3.16: Metal activation graph for GspDAH7PSWT (Blue) compared to GspDAH7PSDAH7PS 
representing the different activation abilities of different metals in comparison to Cd2+ at a 
concentration of 100 µM. Also shown is the degree of inactivation for both enzymes in the presence 
of the metal chelators EDTA and DPA. Reactions were carried out at 60 ᵒC, with 195 µM PEP and 197 
µM E4P in 50 mM BTP buffer (pH 6.8). 
 
As expected, it appears that the removal of the CM domain had little effect on the activation 
abilities of the different metals with Cd2+ still being the most activating metal and Zn2+ being 
the least activating metal ion in comparison to GspDAH7PSWT (Figure 3.16).  
 
3.11 Temperature dependency study of GspDAH7PS
DAH7PS 
As for GspDAH7PSWT, the optimal temperature for GspDAH7PSDAH7PS activity was determined 
through a temperature dependency study using the same experimental methods (section 
2.6). Substrates (PEP and E4P), metal (Cd2+), buffer (50 mM BTP, pH adjusted to the required 
temperature) and enzyme concentrations were kept constant while varying the 
temperature of the reaction mixture. Once the reaction mixture in the cuvette had 
equilibrated to the required temperature, enzyme was added to the mixture and incubated 
for one minute before initiation of the reaction with E4P. The experiment was later 
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repeated with the enzyme incubated for longer period of five minutes, to determine the 
effects of a longer incubation time (Figure 3.17). 
 
 
Figure 3.17: Temperature dependent graph for GspDAH7PSWT and GspDAH7PSDAH7PS showing enzyme 
activity at different temperatures. Substrate (325 µM PEP, 475 µM E4P for GspDAH7PSWT and 337 
µM PEP, 356 µM E4P for GspDAH7PSDAH7PS), metal (100 µM Cd2+), buffer (50mM BTP, pH 6.8) and 
enzyme (5 µL at 0.21 mg/mL for GspDAH7PSWT and 3 µL at 0.14 mg/mL for GspDAH7PSDAH7PS) 
concentrations were kept constant. Enzymes were incubated at desired temperature with the 
reaction mixture for either one minute (shown in dark blue for GspDAH7PSWT and in red for 
GspDAH7PSDAH7PS) or five minutes (shown in light blue for GspDAH7PSWT and in light red for 
GspDAH7PSDAH7PS). 
 
The results show that just like the wild-type enzyme, GspDAH7PSDAH7PS was most active at 
70 ᵒC and least active at 30 ᵒC under the given conditions. For both enzymes, activity 
increases as temperature increases, up to temperatures as high as 70 ᵒC, and then drops at 
80 ᵒC. This result suggest that both GspDAH7PSWT and GspDAH7PSDAH7PS may very well be 
denaturing at such high temperatures, with both enzymes determined to have a Tm below 
80 °C according to DSF data (section 3.9), resulting in the decreased activity reading. 
Another possible explanation for the lost in activity at 80 °C could be a result of substrate 
degradation, where the substrate breaks down before reaching the active site of the 
catalytic DAH7PS domain. The different incubation times had no effect on the enzymatic 
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activity of GspDAH7PSDAH7PS except at 60 ᵒC, where the mutant was significantly more active 
when incubated for five minutes in comparison to one minute (Figure 3.17). 
 
3.12 Temperature dependency study of GspDAH7PS
CM 
The temperature dependency study was also carried out on GspDAH7PSCM with the same 
method used for GspDAH7PSWT where the substrate (CA), buffer (pH adjusted for 
experimental temperatures) and enzyme concentrations were kept constant while only 
varying the temperature (section 2.7). The enzyme was incubated (after equilibration was 
achieved) with the reaction mixture for either one minute or five minutes before initiation 
of the reaction with CA (Figure 3.18). 
 
Figure 3.18: Temperature dependent graph for GspDAH7PSWT and GspDAH7PSCM showing enzyme 
activity at different temperatures (30 °C, 40 °C, 50 °C, 60 °C, 70 °C and 80 °C) with no added metal 
ions. Substrate (70 µM CA for GspDAH7PSWT and 80 µM CA for GspDAH7PSCM) buffer (50mM BTP, pH 
6.8) and enzyme (3 µL at 12.97 mg/mL for GspDAH7PSWT and 5 µL at 5.29 mg/mL for GspDAH7PSCM) 
concentrations were kept constant. Enzyme was incubated at desired temperature with the reaction 
mixture for either one minute (shown in dark blue for GspDAH7PSWT and in green for GspDAH7PSCM) 
or five minutes (shown in light blue for GspDAH7PSWT and in light green for GspDAH7PSCM). 
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The results show that both GspDAH7PSWT and GspDAH7PSCM CM enzyme activity increases 
as temperature increases. The wild-type enzyme is most active at 70 ᵒC, and then the 
activity dramatically drops at 80 ᵒC, possibly due to substrate degradation. This is unlike the 
truncation mutant that is most active at only 60 ᵒC, with enzymatic activity reduced at 70 ᵒC 
and decreased to a greater extent at 80 ᵒC (Figure 3.18). This result is consistent with the 
DSF data for GspDAH7PSCM that shows that under similar conditions the enzyme has a Tm of 
69 ± 0.2 ᵒC, significantly lower than the wild-type enzyme which under the same conditions 
has a Tm of 76.7 ± 0.2 ᵒC (section 3.9). This result suggests that the truncation mutant at 70 
ᵒC is slowly denaturing and therefore giving the reduced activity reading.  
Incubating the wild-type enzyme with the reaction mixture for either one or five minutes did 
not have an effect on the activity of the enzyme. In the case of the truncation mutant, it 
appears that incubating the enzyme with the reaction mixture at a temperature of choice 
meant that the enzyme was slightly more active (up to temperatures of 60 °C), at five 
minutes of incubation, than incubating it for one minute with the reaction mixture (Figure 
3.18). This suggests that GspDAH7PSCM requires a longer incubation time to reach full 
activity. 
 
3.13 Michaelis-Menten kinetics of GspDAH7PS
DAH7PS
 
A comparison of kinetic parameters between GspDAH7PSWT and GspDAH7PSDAH7PS was 
required in order to find out just how much of an effect the removal of the CM domain had 
on the catalytic domain’s ability to mediate its reaction.  The steady state kinetic parameters 
for GspDAH7PSDAH7PS were measured using the same spectrophotometric assay at 60 ᵒC 
(Figure 3.19). The apparent Km values for PEP and E4P were found to be 98 ± 11 µM and 62 ± 
5 µM respectively, with a calculated kcat value of 63 ± 5 s
-1 (Table 3.1). 
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Figure 3.19: Michaelis-Menten plots obtained for GspDAH7PSDAH7PS showing the apparent PEP (left) 
Km with a value of 98 ± 11 µM and E4P (right) Km with a value of 62 ± 5 µM. A kcat value of 63 ± 5 s
-1 
was obtained. Standard assays were carried out at 60 °C in 50 mM BTP and 100 µM Cd2+. 
 
Compared to the full-length wild-type protein, GspDAH7PSDAH7PS has a similar Km
PEP value, 
with a slightly lower Km
E4P value. GspDAH7PSDAH7PS is more active than GspDAH7PSWT with a 
kcat value that is roughly 1.4 fold higher than the kcat value calculated for GspDAH7PS
WT (45 ± 
4 s-1). 
 
Table 3.1: Kinetic parameters for the enzymes GspDAH7PSWT and GspDAH7PSDAH7PS 
Enzyme Km
PEP (µM) Km
E4P (µM) kcat (s
-1) kcat/Km
PEP(µM.s-1) kcat/Km
E4P(µM.s-1) 
GspDAH7PSWT  87 ± 9 
 
95 ± 8 
 
45 ± 4 0.52 0.47 
GspDAH7PSDAH7PS 98 ± 11 
 
62 ± 5 
 
63 ± 5   0.64 1.0 
 
3.14 Michaelis-Menten kinetics of GspDAH7PS
CM
 
The steady state kinetic parameters for GspDAH7PSCM were measured by tracking the 
consumption of CA at 274 nm (Figure 3.20). The continuous spectrophotometric assay for 
the enzyme was carried out at 50 ᵒC 
Initial velocities for the catalytic CM activity of GspDAH7PSCM were measured by initiating 
the equilibrated reaction mixture with varying concentrations of CA. The apparent Km value 
GspDAH7PSCM  was found to be 450 ± 42 µM, with a calculated kcat value of 5.5 ± 0.52 s
-1   
(Table 3.2).  
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Figure 3.20: Michaelis-Menten plot obtained for GspDAH7PSCM showing the apparent CA Km with a 
value of 450 ± 42 µM . A kcat value of 5.5 ± 0.52 s
-1 was obtained for GspDAH7PSCM. Standard assays 
were carried out at 50 °C in 50 mM BTP (pH 6.8) without the addition of any metal ions. 
 
Compared to the full-length wild-type enzyme, GspDAH7PSCM has a Km
CA value that is 
significantly higher. GspDAH7PSCM is more active, at maximal activity, than the wild-type 
enzyme with a kcat value that is roughly 2.9 fold higher. Analysis of the kcat/Km
 CA values 
suggests that GspDAH7PSWT is the better catalyst at 2.1x10-2 µM.s-1 in comparison to 
GspDAH7PSCM with a value of 1.2x10-2 µM. s-1. 
 
Table 3.2: Kinetic parameters for the enzymes GspDAH7PSWT and GspDAH7PSCM 
Enzyme Km
CA (µM) kcat (s
-1) kcat/Km
 CA (µM.s-1) 
GspDAH7PSWT 88 ± 6 
 
1.9 ± 0.13   2.1x10-2 
GspDAH7PSCM 450 ± 42 
 
5.5 ± 0.52   1.2x10-2 
 
 
3.15 Feedback inhibition
 
of GspDAH7PS
DAH7PS 
An inhibition study was carried out on GspDAH7PSDAH7PS to investigate what effect the 
removal of the CM domain has on the response of the enzyme to PA (Figure 3.21). DAH7PS 
domain activity was tested using a continuous spectrophotometric assay at 60 ᵒC, where the 
consumption of PEP was monitored at 232 nm. Substrates (PEP, E4P), metal (Cd2+), and 
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enzyme concentrations were kept constant in 50 mM BTP buffer (pH 6.8), while the 
concentration of PA was varied. 
 
Figure 3.21: Response of GspDAH7PSWT (blue) and GspDAH7PSDAH7PS (red) activity to increasing 
concentrations of PA. Standard assays were carried out at 60 ᵒC, with 121 µM PEP and 123 µM E4P 
in 50 mM BTP buffer (pH 6.8). The data points were measured in triplicate with error bars indicating 
the standard deviation. 
 
Results show no reduction in enzymatic activity for GspDAH7PSDAH7PS in the presence of PA 
at any concentration. This is in contrast to the wild-type enzyme, which was completely 
inhibited by PA and shows that the CM extension to the barrel is necessary for inhibition by 
PA. 
 
3.16 Analytical SEC of GspDAH7PS
DAH7PS 
Another technique used to examine the structure of GspDAH7PSDAH7PS was analytical size 
exclusion chromatography (SEC) (gel filtration) (Figure 3.22). This technique determines 
molecular masses of proteins by using a column that separates proteins based on their size, 
with larger proteins eluting first followed by the smaller proteins. In the case of 
GspDAH7PSDAH7PS, this technique was used to determine if the enzyme exists as a single or 
multiple species in solution. By loading different enzyme concentrations onto the column, 
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the technique also determines whether the quaternary structure of the enzyme is 
concentration dependent. The analytical SEC column was calibrated using protein standards 
with known molecular weights, to allow estimation of the molecular weight of the protein 
being eluted, based on elution volume. The molecular weight of eluted GspDAH7PSDAH7PS 
was determined based on a standard curve of the log of molecular weight against elution 
volume/void volume (Ve/Vo) of protein standards. 
 
 
Figure 3.22: Analytical SEC traces (normalised) and standard curve of log molecular weight versus 
elution volume/void volume for GspDAH7PSDAH7PS at 1 mg/ml (black trace) and 0.5 mg/ml (red trace). 
Injection volume was 500 µL for each sample. 
 
Two different concentrations (1 mg/mL, 0.5 mg/mL) of GspDAH7PSDAH7PS were injected onto 
the column with the enzyme eluting in two peaks for both runs. The enzyme eluted in the 
first peak corresponded to the molecular weights of 117 kDa and 120 kDa for the first run 
and the second run respectively. The enzyme eluted in the second peak corresponded to the 
molecular weight of 28.9 kDa and 29.1 kDa for the first run and the second run respectively. 
This indicates that the enzyme exists both as a monomer and a tetramer in solution. There is 
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a small shift in oligomeric state favouring tetramer formation as the enzyme concentration 
is increased. 
 
3.17 Analytical ultracentrifugation of GspDAH7PS
DAH7PS 
Gel filtration traces of GspDAH7PSDAH7PS show the enzyme elutes in two peaks. SDS-PAGE 
analysis determined that both peaks contain GspDAH7PSDAH7PS. Activity assays showed that 
both of the peaks were active. Analytical SEC data indicated that the enzyme exists in 
equilibrium between a tetrameric and monomeric state. To further investigate the 
quaternary assembly of GspDAH7PSDAH7PS in solution, an analytical ultracentrifugation (AUC) 
experiment was run on different concentrations of the enzyme (Figure 3.23). 
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Figure 3.23: Sedimentation velocity analysis of GspDAH7PSDAH7PS at 1.8 mg/ml (black line), 1 mg/ml 
(blue line) and 0.5 mg/ml (red line). Experiments were carried in SEC buffer (pH 7.4 at 20 ᵒC). Data 
was collected at 50,000 rpm at a wavelength of 280 nm. (A) the best fit of the experimental data. (B) 
the distribution of the species. 
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Stock solutions of GspDAH7PSDAH7PS were buffer exchanged into freshly made SEC buffer (10 
mM BTP, pH 7.4, 40 mM KCl, 200 µM PEP and 10 µM EDTA) and diluted to three different 
concentrations (1.8 mg/mL, 1 mg/mL and 0.5 mg/mL). Using AUC each sample was run 
along with a blank containing an exact buffer match to ensure a precise profile of the 
enzyme in solution is obtained. 
 
The absorbance versus radial position data show the presence of three sedimentation 
boundaries for GspDAH7PSDAH7PS, suggesting that under the experiemental conditions, the 
enzyme exists as three oligomeric species in solution. A best fit of the experimental data 
showed the presence of three species that had sedimentation coefficients of 2.6 S, 4.1 S and 
6.4 S. Fitting the sedimentation velocity data, correlated to calculated masses of 37 kDa, 72 
kDa and 130 kDa for GspDAH7PSDAH7PS. This is consistent with the molecular masses for the 
monomer (30 kDa), dimer (60 kDa) and tetramer (120 kDa) of GspDAH7PSDAH7PS. 
 
Sedimentation equilibrium experiments at different concentrations were carried out to 
ensure that equilibrium between the three oligomeric states was being observed. 
Normalising the tetrameric sedimentation coefficient boundaries obtained to one for all 
concentrations showed that as the concentration of enzyme increased, tetramer formation 
was favoured with a reduced monomer formation. 
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3.18 Summary 
The genes encoding for GspDAH7PSDAH7PS and GspDAH7PSCM were both amplified from the 
plasmid containing the GspDAH7PSWT gene and ligated into the vectors of choice, which 
were then transformed into the desired host cells. Both truncated variants were expressed 
and purified successfully by using the appropriate columns, with size exclusion 
chromatography being the final step in the purification procedure. Mass spectrometry 
determined that both enzymes were of the expected mass.  
As for GspDAH7PSWT, DSF results showed that different metal ions in comparison to EDTA 
had different stabilising effects on GspDAH7PSDAH7PS. With no added metal, both 
GspDAH7PSDAH7PS and GspDAH7PSCM were less stable in comparison to the wild-type 
enzyme. Cd2+ and Zn2+, the two metal ions that brought about two distinct rises in 
florescence consistent with a two stage thermal denaturation response for the wild-type 
enzyme, were the most stabilising metal ions for GspDAH7PSDAH7PS, and most destabilising 
to GspDAH7PSCM.   
GspDAH7PSDAH7PS was found to be metal dependent without much change to the activation 
abilities of the metal ions to the truncated mutant in comparison to the wild-type enzyme, 
with Cd2+ being the most activating metal ion for the enzyme similar to that  observed for 
GspDAH7PSWT.  
Both truncated variant activities were found to be affected by temperature where 
GspDAH7PSDAH7PS gave similar results to the wild-type enzymes DAH7PS activity, with both 
enzymes being most active at 70 ᵒC. GspDAH7PSCM gave a slightly different result with the 
highest enzymatic activity observed at 60 ᵒC, unlike the wild-type enzyme with maximal CM 
activity at 70 ᵒC. 
Michaelis-Menten kinetics obtained through kinetic assays determined that 
GspDAH7PSDAH7PS has a similar Km
PEP value (98 ± 11 µM), with a slightly lower Km
E4P (62 ± 
5µM) value in comparison to the wild-type enzyme that had Km values of 87 ± 9 µM and 95 ± 
8 µM for PEP and E4P respectively. GspDAH7PSDAH7PS was also found to be more active than 
GspDAH7PSWT with a kcat value (63 ± 5 s
-1) that is roughly 1.4 fold higher than the kcat value 
calculated for GspDAH7PSWT (45 ± 4 s-1). GspDAH7PSCM had a significantly higher Km
CA value 
(450 ± 42 µM) Compared to GspDAH7PSWT with a Km
CA value of 88 ± 6 µM. GspDAH7PSCM 
81 
 
was found to be more active that the wild-type protein with a kcat value that is roughly 2.9 
fold higher, yet is a less efficient catalyst at 1.2x10-2 µM. s-1 in comparison to GspDAH7PSWT 
with a value of 2.1x10-2 µM.s-1. 
 
While inhibition studies determined that GspDAH7PSWT was completely inhibited by PA, 
GspDAH7PSDAH7PS showed no signs of inhibition in the presence of the inhibitor. It was 
therefore determined that the CM domain plays a key role in the regulation of the wild-type 
enzyme. 
 
Analytical SEC and AUC data demonstrated that GspDAH7PSDAH7PS exists in multiple 
oligomeric states in solution with the data suggesting that the truncated mutant is in 
equilibrium between the two states. 
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4.Chapter 4  
 
Summary of thesis and future directions 
This thesis describes the characterisation of the type Iβ bifunctional DAH7PS fusion protein, 
GspDAH7PSWT, and the further characterisation carried out on the independently expressed 
truncated domains. 
 
GspDAH7PSWT demonstrated both DAH7PS and CM activity, with the catalytic DAH7PS 
domain requiring a divalent metal ion for catalytic activation. PA completely inhibited the 
DAH7PS activity of GspDAH7PSWT, and according to AUC, causes the wild-type enzyme to 
favour a tetrameric oligomeric state in solution rather than display the dimer-tetramer 
equilibrium that was observed for GspDAH7PSWT in the absence of PA.  
 
4.1 The regulatory and catalytic domains of GspDAH7PS
WT
 were 
successfully separated and expressed independently and both 
domains retained activity. 
Analysis of the sequence of GspDAH7PSWT suggested that the protein consists of two 
functional proteins, a DAH7PS and a CM. The bifunctionality of this protein was 
unequivocally confirmed through the kinetic characterisation of the protein.  Separating the 
DAH7PS and CM domains of GspDAH7PSWT and expressing these independently revealed 
that both domains, GspDAH7PSDAH7PS and GspDAH7PSCM, retained activity on their own. 
These observations demonstrated that both domains are capable of functioning 
independently of one another without a requirement to be tethered.  
 
GspDAH7PSDAH7PS not only retained activity, but was determined to be more catalytically 
active than the wild-type enzyme according to kinetic assays, with a kcat value 1.4 fold higher 
than that recorded for the wild-type enzyme. This increase in activity was also observed for 
the type Iβ TmaDAH7PS, where removal of the fused regulatory FL domain resulted in a 
more catalytically active enzyme, with a kcat value 1.6 fold higher than the wild-type 
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protein.16 Interestingly, the removal of the CM domains found fused to BsuDAH7PS and 
PgiDAH7PS hardly had an effect on the activity for the isolated DAH7PS of BsuDAH7PS, and 
resulted in a PgiDAH7PS domain that had reduced catalytic activity, with a kcat value 2 fold 
less in comparison to the full length enzyme.12   
 
BsuDAH7PS, like GspDAH7PSWT, is another fusion enzyme with an N-terminal CM domain. A 
previous study characterising BsuDAH7PS suggested that this enzyme was not a true 
bifunctional protein, as the CM domain fused to the catalytic domain had very poor 
activity.12 B. subtilis contains another gene encoding for a second highly active AroH CM 
domain responsible for the conversion of CA to PA.60 This CM enzyme serves the organism’s 
primary needs of PA production, rendering the catalytic activity of the CM fused to the 
DAH7PS redundant. This further supported the idea that BsuDAH7PS had acquired this CM 
fusion for the purpose of regulation, rather than for bifunctionality.  
 
Geobacillus sp also contains another gene encoding for a second intracellular AroH CM 
domain, however in the case of GspDAH7PSWT, it should be noted that the enzyme appears 
to be bifunctional as the fused AroQ CM domain in this protein has a much higher activity in 
comparison to the AroQ CM domain fused to BsuDAH7PS. It would be of great interest to 
characterise the AroH CM domain of Geobacillus sp and compare its catalytic efficiency to 
that obtained with the AroQ CM domain of GspDAH7PSWT in this study. It would be 
interesting to determine whether both the AroH and AroQ CM proteins available to 
Geobacillus sp have comparable kinetic parameters. It is conceivable that the AroH CM 
domain of Geobacillus sp may have some sort of functional role that the AroQ CM domain of 
GspDAH7PSWT cannot fulfil. One way to determine this would be to genetically modify 
Geobacillus sp to encode for the fused AroQ CM and not the AroH CM, then observe what 
impact this has on the viability and the properties of the organism. 
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4.2 The removal of the regulatory CM domain left the catalytic 
GspDAH7PS
DAH7PS
 domain activity unaffected by PA, 
suggesting that the CM domain plays a key role for the 
allosteric regulation of GspDAH7PS
WT 
PA was shown to completely inhibit the catalytic activity of GspDAH7PSWT unlike 
GspDAH7PSDAH7PS, which showed no signs of inhibition in the presence of PA at any 
concentration. This suggests that the CM domain of GspDAH7PSWT is necessary for inhibiting 
DAH7PS activity. Clearly while there are benefits for Geobacillus sp in having a regulated 
DAH7PS enzyme, its presence incurs the penalty of reduced catalytic activity. As for 
GspDAH7PSDAH7PS, the truncated catalytic domains of BsuDAH7PS and PgiDAH7PS did not 
demonstrate any sign of inhibition in the presence of inhibitors.12 This was also the case for 
TmaDAH7PS, which was no longer regulated by pathway end products upon removal of the 
FL domain, implying that the FL domain was also required for the regulation of the catalytic 
domain.16 This was confirmed when a comparison between ligand bound and non-ligand 
bound crystal structures of TmaDAH7PS revealed the enzymes mechanism of inhibition, 
whereby the regulatory FL domains from diagonally opposite subunits interact to form a 
binding site for Tyr,  resulting in  physical capping of the active site and inhibition of DAH7PS 
activity. 
 
Elucidating the mechanism of inhibition for GspDAH7PSWT requires further experimental 
work. However, speculation can be made as to how inhibition of the enzyme occurs by 
utilising the data already obtained, and using the structure of the related LmoDAH7PS to 
complement this data.61 LmoDAH7PS consists of a catalytic DAH7PS domain fused to an N-
terminal CM domain and shares 75 % primary sequence identity to GspDAH7PSWT. While no 
functional characterisation has been carried out on LmoDAH7PS, the structural 
characterisation demonstrates its similarity to GspDAH7PSWT. The core of the tetrameric 
state of both enzymes consists of four (β/α)8 barrels that contain the catalytic DAH7PS 
machinery. These core barrel domains alternate in their orientations, where diagonally 
related subunits face the same side of the tetramer. Each DAH7PS catalytic subunit is 
connected to an N-terminal CM domain through a linker region where two CM domains 
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emerging from diagonally related DAH7PS subunits that face the same side of the tetramer 
come together and interact with one another (Figure 4.1).  
 
The crystal structure of GspDAH7PSWT was solved with PA-bound65 and displays a distinct 
conformation to the non-ligand bound crystal structure of LmoDAH7PS. Formation of CM 
dimers loosely associated with DAH7PS subunits is believed to be a key part in the inhibition 
of LmoDAH7PS and GspDAH7PSWT. It is believed that upon binding of PA to the CM dimers, a 
conformational change occurs where loosely associated CM dimers close in and cap the 
active site of the DAH7PS domains, blocking substrate access and therefore inhibiting the 
catalytic domain. The conformational change that occurs is easily achieved due to the highly 
flexible linker connecting the catalytic and regulatory domains, allowing for the capping of 
DAH7PS active sites possible without restrictions. This mechanism of inhibition is further 
supported when comparing the crystal structure of PA-bound GspDAH7PSWT with a non-PA 
bound model of GspDAH7PSWT based on the LmoDAH7PS PA-bound crystal structure. 
(Figure 4.1). The non-PA bound model of GspDAH7PSWT shows that the CM dimers are 
loosely associated with the tetramer in an open conformation, unlike the PA-bound 
structure which clearly shows the CM dimers closely associated with the tetramer in a 
closed form to function as an allosteric cap. 
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Figure 4.1: non-ligand bound (left) and ligand bound (right) tetrameric structures of 
GspDAH7PSWT, with different colours representing different subunits. For the structure on the right, 
each CM subunit has PA-bound shown as green spheres. The structure on the left is a homology 
model based on the structure of LmoDAH7PS (PDB code 3TFC). 
 
The conformational change that GspDAH7PSWT undergoes upon PA binding is not as 
extensive as that of TmaDAH7PS, where the regulatory FL domains must come together to 
form a binding site for the inhibitor leading to the capping of the active site.16 In 
GspDAH7PSWT the regulatory CM domains are already interlocked and in close proximity to 
the active site, ready to cap the active site of the catalytic domain. This could be of 
advantage to GspDAH7PSWT, where such a mechanism would lead to a quicker and more 
precise inhibition. Indeed it has been clearly demonstrated that GspDAH7PSWT is highly 
sensitive to PA according to the inhibition study carried out. 
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4.3 The removal of the CM domain disrupted the tetrameric 
oligomeric state of GspDAH7PS
WT
, thus the catalytic CM 
regulatory domain supports protein structure in addition to 
allosteric regulation. 
SEC traces of GspDAH7PSWT displayed a peak with a shoulder, both determined to contain 
GspDAH7PSWT according to SDS-PAGE analysis. Further experimental work on the wild-type 
enzyme using AUC, determined that the enzyme exists in equilibrium between a dimeric and 
a tetrameric oligomeric state. AUC was also performed on GspDAH7PSDAH7PS, since SEC 
traces for this enzyme also displayed two peaks, with both peaks determined to contain 
GspDAH7PSDAH7PS according to SDS-PAGE analysis. AUC results determined that the 
truncated variant mostly exists in equilibrium between a monomeric and tetrameric state, 
with a small amount of dimer observed. A similar result was also observed by analytical SEC, 
which also determined that the enzyme is in equilibrium between a monomeric and 
tetrameric oligomeric state. Therefore it is clear that the removal of the ancillary CM 
domain from the catalytic DAH7PS domain of GspDAH7PSWT causes a disturbance in the 
quaternary structure, leading to monomer formation. This suggests that the CM domain not 
only regulates DAH7PS activity, but also supports the quaternary structure of the enzyme. 
While truncating the CM domain from GspDAH7PSWT disrupted the quaternary structure, 
the resulting catalytic activity of the enzyme was not compromised, and instead it was 
established that GspDAH7PSDAH7PS is relatively more active in comparison to GspDAH7PSWT. 
This observation suggests that tetramer formation is not necessary for DAH7PS activity. 
 
Preliminary results suggest that the reason for the observed increase in catalytic activity of 
GspDAH7PSDAH7PS in comparison to GspDAH7PSWT is due to the removal of the CM domains 
that would normally be in close proximity to the active sites of the DAH7PS domains. Even if 
inhibition of GspDAH7PSWT requires the CM domains to cap the DAH7PS active sites of the 
tetramer, it is a possibility that in the open more extended confirmation the loosely 
associated CM dimers may well impede catalysis and access of substrates and product 
release. This may account for the observation that GspDAH7PSDAH7PS is more active than the 
wild-type protein, since each DAH7PS domain is more accessible to substrates by not having 
a CM subunit in close proximity to the active site. According to small angle X-ray scattering 
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(SAXS) data, the regulatory FL domains of TmaDAH7PS are rapidly opening and closing even 
in the absence of an inhibitor.16 This alternating conformational change could explain why 
the removal of the regulatory domain produces a variant more catalytically active, where 
the FL domain no longer sterically hinders substrate access to the active site of the DAH7PS 
domain. 
 
While the above explanation for the increased catalytic activity observed agrees with the 
results obtained for GspDAH7PSWT and TmaDAH7PS, another explanation could be that the 
increase in catalytic activity observed for GspDAH7PSDAH7PS is related to the disrupted 
quaternary structure resulting from the CM domain truncation. This idea is supported by 
similar results obtained for TmaDAH7PS, where experimental data suggested that the 
removal of the FL domain caused the enzyme to adopt a dimeric quaternary structure in the 
crystal structure instead of the tetrameric structure adopted by the wild-type enzyme (16 
this thesis). SAXS data did however show that the TmaDAH7PS variant was a tetramer, 
suggesting that the enzyme can populate a different quaternary structure and does not 
necessarily have to be tetrameric. Another finding that greatly supports this explanation 
comes from a recent study carried out on PfuDAH7PS, where the residue Ile, located in the 
hydrophobic interface of the enzyme, was substituted for the residue Asp.70 The resulting 
mutant was found to exist in equilibrium between a dimeric and tetrameric quaternary 
state, unlike the wild-type enzyme which only exists as a single tetrameric species in 
solution. Interestingly, disturbing the quaternary structure of the wild-type enzyme resulted 
in a variant that was 4 fold catalytically more active.  
 
If removing the CM domain of GspDAH7PSWT causes the enzyme to fall apart but 
consequently have an increased catalytic activity, why would Geobacillus sp evolve such a 
fusion enzyme at the expense of reduced catalytic activity? It has been clearly demonstrated 
that GspDAH7PSDAH7PS has no sensitivity to PA, showing that the CM domain is required for 
regulation. The mechanism of inhibition of GspDAH7PSWT requires the enzyme to adopt a 
tetrameric oligomeric state, clearly shown by the crystal structure of the wild-type enzyme 
and by AUC, where GspDAH7PSWT tetramer formation increased significantly in the 
presence of PA. Enzyme regulation provides a great advantage to an organism, as it provides 
the ability to control pathway output in response to metabolic demand. A DAH7PS enzyme 
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possessing the trait of allosteric regulation may be of great importance to Geobacillus sp. It 
is therefore a possibility that this thermophilic bacterium advantageously evolved the 
regulated GspDAH7PSWT, even at the cost of diminished activity. It would be interesting to 
see what would occur, if Geobacillus sp was genetically modified to encode for 
GspDAH7PSDAH7PS rather than GspDAH7PSWT in order to determine what impact this has on 
the viability and the properties of the organism. 
 
The quaternary structure of GspDAH7PSWT appears to be beneficial not for regulation, but 
also for increased thermostability. Geobacillus sp is a thermophillic organism thriving in 
environmental conditions with extreme temperatures.64 Possessing enzymes that are able 
to withstand the high temperatures this organism normally inhabits is of importance. DSF 
data demonstrated that GspDAH7PSWT was more stable at evaluated temperatures in 
comparison to GspDAH7PSDAH7PS in all but one of the conditions tested, where both enzymes 
were equally stable. The study mentioned above where the tetrameric structure of 
PfuDAH7PS was disrupted by a single point mutation, also determined that the resulting 
mutant was significantly less stable at elevated temperatures in comparison to the wild-type 
enzyme.70 This further supports the idea that in addition to regulation, the quaternary 
structure of GspDAH7PSWT promotes added thermostability. So whereas GspDAH7PSDAH7PS is 
more catalytically active in comparison to GspDAH7PSWT, it is less thermostable. 
 
Further investigations using AUC and DSF experiments on other type Iβ DAH7PS enzymes 
such as BsuDAH7PS and PgiDAH7PS, along with their truncated variants that lack a 
regulatory CM domain may prove to be relevant. Characterisation work to help determine 
the quaternary structure and thermostability of the full length enzymes, along with the 
truncated catalytic domains, could provide a better understanding of why DAH7PS enzymes 
display an increase in catalytic activity as a result of having their regulatory domains 
removed. Since it has been shown that the removal of the CM domains found fused to 
BsuDAH7PS and PgiDAH7PS hardly had an effect on the activity for the DAH7PS truncated 
mutant of BsuDAH7PS, and resulted in a PgiDAH7PS truncated mutant with diminished 
activity, would AUC data reveal a lack of disturbance in quaternary structure due to the 
truncation? In addition, would DSF data of the full length enzymes and their respective 
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truncated mutants demonstrate that they have the same thermostability due to a lack of 
disturbance in quaternary structure? 
 
It is unclear why GspDAH7PSWT is in equilibrium between a dimeric and tetrameric 
oligomeric state rather than a tetrameric state only. This finding does seem unusual, 
especially since the enzyme requires the tetrameric oligomeric state for inhibition to occur. 
It is worth noting however that other AUC data carried on GspDAH7PSWT in the presence of 
higher salt concentrations identified the presence of tetramer only. Further investigation is 
required into the quaternary structure of GspDAH7PSWT, where the enzyme is accessed with 
AUC under different environmental conditions ranging in pH, temperature and salt 
concentration. It is possible that the cellular conditions of Geobacillus sp promote the 
formation of tetramer only, which would be favourable for regulation and stability of the 
enzyme, especially under extreme temperatures. 
 
4.4 Future experiments 
Now that it has been determined that the CM domain of GspDAH7PSWT is required for 
regulation, it would be interesting to determine if it is possible to transfer the CM domain of 
GspDAH7PSWT, and fuse it to the catalytic barrel of a DAH7PS enzyme from a different 
source. It has been previously shown that transfer of the FL domain of TmaDAH7PS to the 
unregulated PfuDAH7PS, resulted in a chimeric enzyme that was regulated by Tyr, and to a 
lesser extent by Phe.50 Would transferring the CM domain of GspDAH7PSWT to PfuDAH7PS 
form a chimeric enzyme that is inhibited by PA? What would occur if the same experiment 
was carried out but instead, fusing the CM domain to PfuDAH7PS previously mentioned that 
contains the single point mutation that disrupts the homotetramer?  
 
The reverse experiment could also be carried out where the catalytic domain of 
GspDAH7PSWT is fused to the regulatory domain of another type Iβ DAH7PS enzyme such as 
the FL domain TmaDAH7PS. Would this chimeric protein have comparable kinetic 
parameters to GspDAH7PSWT? 
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Conclusion 
Understanding the mechanism of regulation in DAH7PS enzymes is a very important part of 
unravelling how these enzymes evolved and the reasons behind it. GspDAH7PSWT evolved to 
be regulated through the acquisition of an ancillary CM domain. The results obtained 
through the characterisation of GspDAH7PSWT provided some insight into the enzymes 
mechanism of regulation and in turn, contributed towards a better understanding of the 
diverse methods of regulation found in the DAH7PS enzyme family. 
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5.Chapter 5 
Experimental procedures 
 
5.1 General methods 
5.1.1 Amino acid sequence alignments 
Multiple amino acid sequence alignments were generated using ClustalW 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
 
5.1.2 Protein structure figures 
All protein structure figures were created using the PyMOL™ Molecular Graphics System 
(version 1.3, Schrödinger LLC) 
 
5.1.3 Purified water 
All water was purified by passage through a Millipore Milli-Q water system. This is referred 
to as Milli-Q water throughout this thesis. All Milli-Q water used for molecular biology was 
autoclaved prior to use. 
 
5.1.4 pH measurement 
The pH of all solutions was measured at room temperature or at kinetic assay temperatures 
unless otherwise stated using a Mettler Toledo SevenCompactTM 220 pH probe. The pH of 
solutions was adjusted using 1 M or 10 M HCl and 1 M or 10 M NaOH. 
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5.1.5 Removal of metal ions from solution 
Metal ions were removed from solution by treatment with Chelex® 100 resin (Bio-Rad). The 
resin was added and left to stir overnight before the resin was removed by filtration. The pH 
of all solutions was re-adjusted after Chelex® treatment. 
 
5.1.6 Antibiotic stocks 
Ampicillin (100 mg/mL), kanamycin (100 mg/mL) and spectinomycin (10 mg/mL) stocks were 
all made up using milliQ water unlike chloramphenicol (25 mg/mL) which was made up in 
analytical grade ethanol. All solutions were filtered and then aliquoted into sterile 
microtubes and stored at 80 ᵒC. 
 
5.1.7 Centrifugation 
All centrifugation was carried out using the following: 
• Sorvall Evolution RC (Thermo Scientific) 
• Heraeus Multifuge 1 S-R (Thermo Scientific) 
• Heraeus Pico 17 (Thermo Scientific) 
• Minispin® Centrifuge (Eppendorf) 
 
5.1.8 Growing E. coli cells 
For every 1 L culture, a 50 mL preculture containing the appropriate antibiotic was 
inoculated from the glycerol stock and grown at 37 ᵒC overnight. Once grown, cells were 
transferred to the baffled flasks containing lysogeny broth (LB) solution and correct 
antibiotics where the main culture was grown at 37 ᵒC with shaking at 180 RPM until an 
OD600 of 0.4-0.6 was reached. 
 
5.1.9 Cell induction 
Proteins expression was achieved with the addition of IPTG (0.5 mM final concentration) to 
the cells that had reached the desired OD600. Cultures were then incubated at 37 ᵒC for four 
95 
 
hours for the expression of GspDAH7PSWT, or incubated at 23 ᵒC overnight for the 
expression of the GspDAH7PSDAH7PS and GspDAH7PSCM variants. Cultures incubated at 23 ᵒC 
were left to sit at room temperature for twenty min before the addition of IPTG to ensure 
protein expression at the desired temperature. 
 
5.1.10 Harvesting of cells 
Cells were harvested (four hours after induction for GspDAH7PSWT and one night after 
induction for GspDAH7PSDAH7PS and GspDAH7PSCM) centrifugation (14000 g, 4 ᵒC, twenty five 
min). Once cells pellets were obtained, they were stored at -80 ᵒC until needed. 
 
5.1.11 Cell lysis  
Cells were lysed by sonication using an Omni- Ruptor 4000 Ultrasonic Homogenizer (Omni 
international) with either a titanium 3/8 inch or 5/32 inch probe. 20 ml lysis buffer 
containing half a tablet of protease inhibitor cocktail tablet, EDTA (SIGMAFASTTM) dissolved 
was used to resuspend the cell pellets of the His-tagged proteins. The suspended cells were 
placed in a beaker surrounded with ice and sonicated with 4-5 multiples of five min, at 80 % 
power for the 3/8 inch probe and 40 % power for the 5/32 inch probe with the pulser set at 
35.  
The lysis buffer used for GspDAH7PSWT was composed of 50 mM Bis-tris propane (BTP), 200 
mM KCl, 200 µM PEP and 2mM dithiothreitol (DTT) pH 7.3. 
The lysis buffer used for GspDAH7PSDAH7PS was composed of 20 mM sodium phosphate, 0.5 
M NaCl, 20 mM imidazole, pH 7.4 (HisTrap HP Binding buffer). 
The lysis buffer used for GspDAH7PSCM was composed of 140 mM NaCl, 2.7 mM KCl, 10 mM 
Na2HPO4, 1.8 mM KH2PO4, pH 7.3 (GSTrap binding buffer) 
Proteins were separated from lysed cells by centrifugation (14000 g, 4 °C, twenty five min, 
or 40,000 g, 4 °C, twenty five min)  
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5.1.12 Measuring protein concentration 
A Nanodrop ND-1000 spectrophotometer (Thermo Scientific) was used to measure the 
concentrations of all proteins by adopting Beers Law. The buffer that the protein was stored 
in was used to blank the Nanodrop, and 2 µL of the purified protein along with its calculated 
extinction coefficient value (http://web.expasy.org/protpram/) were used to calculate the 
concentration.  
 
5.1.13 Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE)  
SDS-PAGE was performed using pre-cast gels using NuPAGE® 10 % Bis-tris Gel 1.0 mm × 12-
well pre-cast gels (Invitrogen) in NuPAGE® MOPS SDS Running Buffer (Invitrogen). 
Electrophoresis was performed using a XCell SureLock™ Electrophoresis Cell (Invitrogen), at 
200 V for fifty min. Samples were mixed with NuPAGE® LDS Sample Buffer (4×) and DTT, and 
boiled before loading. 
 
5.1.14 Buffer exchange and concentration of protein 
Proteins were concentrated during and after purification using either a 20 mL 10 000 Da 
molecular weight cut-off (MWCO) device for GspDAH7PSWT and GspDAH7PSDAH7PS or a 20 mL 
5000 Da MWCO device for GspDAH7PSCM (Sartorius Stedim Biotech). All filtration devices 
were washed before use with 2-3 equivalent volumes of Milli-Q water. Protein solutions 
were buffer-exchanged by dilution with the desired buffer and repeatedly concentrated. 
 
5.1.15 Determination of substrate concentration  
The concentrations of PEP and E4P were determined using the standard assay system. Used 
by Schoner and Herrmann,71 as modified by Schofield et al.40 for use at 60 °C. The 
consumption of PEP was monitored at 232 nm (€ of 2.6 × 103 M−1 cm−1 at 60 °C) using a 
Varian Cary 100 UV Visible Spectrophotometer. In the case of E4P, a reaction mixture 
consisting of approximately 300 µM PEP, 100 µM Cd2+, enzyme and 50 mM BTP buffer (pH 
6.8) is made up before being initiated with the addition of 4µL of E4P stock solution 
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(unknown concentration) to give a final concentration of 1 mL. The reaction is allowed to go 
to completion and the difference in absorbance before initiation with E4P and the 
absorbance at completion of the reaction is measured. To convert absorbance into 
concentration the Beer-Lambert Law is applied (A = ɛ c l, where l = 1cm and ɛ of 2.6 x 103 M-
1 cm-1 at 60 ᵒC). 
 
5.1.16 Storage of enzymes 
Before storage, all purified enzymes were split into aliquots of 50 μL, snap frozen in liquid 
nitrogen and stored at −80 °C 
 
5.1.17 Measurement of molecular weight 
The masses of purified proteins were measured by electrospray ionisation using Bruker 
maXis™ 3G (Bruker Daltonics). Proteins were diluted from stored concentrations to 1 mg 
mL−1 with Milli-Q water. 
 
5.1.18 Assays performed at 60 ᵒC  
Reaction mixtures containing 50mM BTP buffer (adjusted to have a pH of 6.8 at 60 ᵒC), CdCl2  
and PEP were incubated for six min at 60 ᵒC before the addition of enzyme. The reaction 
mixture was further incubated for one to five min depending on the experiment being 
carried out, before initiation the reaction with the addition of E4P. Triplicate readings of all 
measurements were recorded and averaged. 
 
5.2 Methods for chapter two 
5.2.1 Differential scanning fluorimetry  
Melt temperatures of all the proteins were determined in the presence of different 
additives by DSF, using an iCycler iQ5TM Multicolour Real-Time PCR Detection System (Bio-
Rad). Triplicate protein samples were added with mixing to buffer (containing additives) and 
SYPRO orange dye (Life Technologies) in a 96-well microplate, which was then sealed. The 
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melt proceeded in 0.2 ᵒC increments from 20 ᵒC to 95 ᵒC, with a 20 s dwell time after each 
temperature rise. Measurements of the fluorescence were made at the end of each dwell 
time. 
For each sample (three replicates and blank) 100 µL of buffer (10 mM BTP, pH 7.4, 40mM 
KCl, 200 µM) including any additives(s) was prepared, to which 5 µL of 250x SYPRO orange 
dye was added. In the blank well for the sample, 21 µL of the solution was added to 4 µL of 
water or buffer. Then, 16 µL of protein (at 1 mg/mL) was added to the remaining condition 
solution before 25 µL was dispensed into three replicate wells. In all experiments, each 
additive was at a final concentration of 100 µM. 
For analysis an Excel spread sheet with custom VBA-scripted macro was created to toggle 
and dynamically display melt and derivative curves for each sample. The melt temperatures 
were calculated as the temperature of maximum infliction of the melting curve after 
subtracting the reading of a blank well containing buffer and dye but lacking protein. 
 
5.2.2 Metal activation  
The metal activation profile of GspDAH7PSWT was determined using standard assays with 
195 µM PEP and 197 µM E4P in 50 mM BTP buffer Chelex®-treated and filtered, pH 6.8 at 60 
°C and 100 µM Cd2+, Mn2+, Mg2+, Zn2+, Ni2+, Co2+, EDTA, DPA or no condition (control). The 
enzyme (5 µL at 0.23 mg/mL) was incubated and left to equilibrate with the reaction 
mixture for 5 min at 60 ᵒC prior to activation with E4P, to a final volume of 1 mL Triplicate 
assays were performed and averaged. 
 
5.2.3 Temperature dependency study  
The temperature dependency profile of GspDAH7PSWT was determined using standard 
assays. Substrate concentrations were kept constant with 325 µM PEP and 475 µM E4P in 
50 mM BTP buffer Chelex®-treated and filtered, pH 6.8, at the desired temperature with 100 
µM Cd2+. The reaction mixture was left to equilibrate at the chosen temperature. At each 
temperature (30 °C, 40 °C, 50 °C, 60 °C, 70 °C and 80 °C), the enzyme, 5 µL at 0.21 mg/mL 
(0.26x10-2 µM in cuvette) was then incubated and left to equilibrate with the reaction 
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mixture for either one or five min prior to activation with E4P, to a final volume of 1 mL. 
Triplicate assays were performed. 
 
5.2.4 Temperature dependency study (chorismate mutase activity) 
The temperature dependency profile of GspDAH7PSWT observing catalytic CM activity was 
determined using standard assays. The substrate concentration was kept constant with 70 
µM CA in 50 mM BTP buffer Chelex®-treated and filtered, pH 6.8 at the desired 
temperature. The reaction mixture was left to equilibrate at the chosen temperature. At 
each temperature (30 °C, 40 °C, 50 °C, 60 °C, 70 °C and 80 °C), the enzyme, 3 µL at 12.97 
mg/mL (0.94 µM in cuvette) was then incubated and left to equilibrate with the reaction 
mixture for either one or five min prior to activation with CA, to a final volume of 1 mL. 
Triplicate assays were performed. 
 
5.2.5 Michaelis-Menten kinetics 
The assays performed to determine the kinetic parameters for GspDAH7PSWT were carried 
out in 1 cm path length quartz cuvettes. Standard reaction mixtures contained 100 µM Cd2+, 
5 µL at 0.232 mg/mL (2.8x10-2 µM in cuvette) (Km
PEP), 5 µL at 0.288 mg/mL (3.5x10-2 µM in 
cuvette) (Km
E4P) enzyme in 50 mM BTP buffer (pH 6.8), giving a total volume of 1 mL. To 
determine Km
E4P, the PEP concentration was fixed at 338 µM while the E4P concentration 
was varied (12 µM to 384 µM). For determination of Km
PEP, E4P concentration was fixed at 
329 µM while the PEP concentration was varied (27 µM to 410 µM).  
 
5.2.6 Michaelis-Menten kinetics (chorismate mutase activity) 
The assays for determining the kinetic parameters for GspDAH7PSWT were carried out in 1 
cm path length quartz cuvettes. Standard reaction mixtures contained 2 µL 12.97 mg/mL 
(0.63 µM in cuvette) enzyme in 50mM BTP buffer (pH 6.8), giving a total volume of 1 mL. To 
determine the Km
CA different concentrations of CA were used varying form (7 µM to 298 
µM)  
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5.2.7 Feedback inhibition 
The inhibition profile of GspDAH7PSWT was determined using standard assays. Varying 
concentrations of PA were added to make a 1 mL solution consisting of Chelex®-treated and 
filtered 50 mM BTP buffer (pH 6.8 at 60 ᵒC), Cd2+ (100 µM), PEP (121 µM) and enzyme (10 
µM at 0.11 mg/mL). The reaction mixture was incubated at 60 ᵒC for ten min to equilibrate 
prior to initiating the reaction by addition of E4P (123 µM). All reactions were performed in 
triplicate and averaged. 
 
5.2.8 Analytical ultracentrifugation 
Sedimentation velocity and sedimentation equilibrium experiments were performed in a 
Beckman Coulter Model XL-I analytical ultracentrifuge equipped with UV/Vis scanning 
optics. Reference buffer solution (10 mM BTP, pH 7.4, 40 mM KCl, 200 µM PEP and 10 µM 
EDTA) and sample solutions were loaded into 12 mm double-sector cells with quartz 
windows. The cells were then mounted in an An-60 Ti 4-hole rotor. GspDAH7PSWT samples 
at a concentration of 1.8 mg/mL, 1 mg/mL and 0.5 mg/mL (380 μL) and reference (400 μL) 
were centrifuged at 50,000 rpm at 20 °C and absorbance data were collected in continuous 
mode at 278 nm without averaging. The sample that was run in the presence of PA was run 
at a concentration of 1 mg/ml in the presence of 500 µM PA, with a reference buffer 
solution of  10 mM BTP, pH 7.4, 40 mM KCl, 200 µM PEP, 10 µM EDTA and 500 µM PA. 
 
Data were fitted to a continuous size distribution model72 using the program SEDFIT. The 
partial specific volume (v) of the sample (0.7463 mL g−1), buffer density (1.0004 g mL−1) and 
buffer viscosity (1.004 cP) were calculated using the program SEDNTERP.73  
 
5.3 Methods for chapter three 
5.3.1 Amplification of GspDAH7PSDAH7PS and GspDAH7PSCM ORF 
The plasmid containing the gene coding for GspDAH7PSWT was used as the template for 
cloning out the ORF of GspDAH7PSDAH7PS and GspDAH7PSCM variants. This was achieved by 
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designing the appropriate primers and the use of the iProofTM High-Fidelity DNA polymerase 
PCR kit (BioRad). 
Nested PCR was the technique used to clone both truncation variants which required two 
PCR rounds, with the second round adding extensions encoding the recombination sites to 
the amplified genes which allows the gene products to be inserted into the desired entry 
vector. 
GspDAH7PSCM primers (Round 1) 
Forward primer: 5’-GGC AGC GGC GCG ATG GGT AAT GAA CGT CTG 
Reverse primer: 5’-GAA AGC TGG GTG TTA TTT ACG ATG ATC ATC TTC 
 
GspDAH7PSDAH7PS primers (Round 1)  
Forward primer: 5’-GGC AGC GGC GCG ATG GCA CTG CTG GTT AGC 
Reverse primer: 5’- GAA AGC TGG GTG TTA CTC GAG TGC ACG AAC 
 
Generic primers (round 2) 
Forward primer: 5’GGG GAC AAG TTT GTA CAA AAA AGC AGG CTT CGA AAA CCT 
GTA TTT TCA GGG CAG CGG CGC G  
Reverse primer: 5’GGG GAC CAC TTT GTA CAA GAA AGC TGG GT 
 
Each PCR mixture contained a total volume of 50 µL consisting of approximately 39.5 ng/µL 
of PET-28b GspDAH7PSWT plasmid DNA, 0.5 µM of round one primers, 200 µM of each of the 
deoxyribonucleotide triphosphates (dNTPs), 10 µL of 5x iProof HF Buffer and 0.02 U/µL 
iProof DNA polymerase. The remaining volume was made up using autoclaved milliQ water.  
Once round one PCR successfullyamplified GspDAH7PSDAH7PS and GspDAH7PSDAH7PS, the PCR 
products were used as the templates for round two of nested PCR using the generic round 
two primers. Round two PCR used the same concentrations of all the components of round 
one PCR. Round two PCR for GspDAH7PSDAH7PS contained approximately 12 ng of the 
amplified product from round one PCR while round two PCR for GspDAH7PSCM truncation 
variant consisted of approximately 19 ng of the amplified product from round one PCR.  
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Round one PCR of the thermo-cycling program consisted of an initial denaturation at 98 ᵒC 
for thirty sec followed by 35 cycles of denaturation for ten sec, primer annealing at 45 ᵒC for 
GspDAH7PSDAH7PS gene and 50 ᵒC for GspDAH7PSCM gene for thirty sec with extension at 72 
ᵒC (thirty sec for GspDAH7PSDAH7PS and fifteen sec for GspDAH7PSCM. Round two PCR 
followed the same protocol for both variants, the only difference was that the annealing 
temperature of the PCR reaction for GspDAH7PSCM truncation variant was 45 °C. 
PCR products were treated with Dpn1, 1 µL was used for each reaction mixture and 
incubated at 37 ᵒC for one hour and purified using E-Gel® CloneWellTM Gel. 
 
5.3.2 Agarose gel electrophoresis 
In order to determine if PCR was successful, an agarose gel had to be prepared. The gel 
separates DNA fragments based on size and this in turn shows if a PCR product with the 
expected number of base pairs was formed. The gel was composed of 1 % Seakem® LE 
agarose, 39.2 mL milliQ and 800 µl of 50x tris base-acetic acid-EDTA (TAE) buffer (2 M tris-
HCl, 1 M glacial acetic acid, 100 mM EDTA). All components were mixed and heated in a 
microwave until the agarose had dissolved, then incubated at 60 ᵒC to equilibrate and then 
then left to cool slightly before adding 4 µL of SYBR® Safe DNA gel stain (Life Technologies). 
Each sample had 2 µl of 6x loading buffer (60 mM tris-HCl, 60 mM EDTA, 0.02 % (w/v) 
orange G, 0.05 % (w/v) xylene cyanol FF, 60 % glycerol). The gel was run in a buffer made 
from 5 mL of 50x TAE buffer mixed with 245 ml milliQ water using a mini-sub cell GT (Bio-
Rad) at 85 volts for forty five min. Gels were examined using an Imager® Gel DocTM XR (Bio-
Rad) UV light at 302 nm. 
Alternatively, DNA samples were loaded on an E-Gel® 1.2 % precast agarose gel (Life 
Technologoes) in a buffer-free system and run for twenty seven min. Separation could be 
monitored in real-time using the E-Gel ® iBase™ Power System and E-Gel® Safe Imager™ 
Transilluminator at 480 nm. For size comparison, DNA fragments were run alongside a 1 kB 
Plus DNA ladder (Life Technologies).  
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5.3.3 BP recombination reaction into pDONR 221 
Once a PCR product (contains attB sites added in round two PCR) was obtained, it was 
ligated into the entry vector pDONR 221 (containing attP sites) through recombination with 
the use of Gateway® BP Clonase® II enzyme mix. The reaction was carried out by adding 
cloned  DNA segments (approximately 68 ng for GspDAH7PSDAH7PS and 138 ng for 
GspDAH7PSCM), 150 ng of pDONR 221 entry vector and adding enough TE buffer (10 mM 
tris/HCl, 1 mM EDTA  pH 8) to the reaction components to give a final volume of 8µL . The 
reaction was initiated with the addition of BP clonase, and then incubated at 25 ᵒC for one 
hour before halting the reaction with the addition of proteinase K and incubating the 
reaction mixture at 37 ᵒC for ten min. 
 
5.3.4 Transformation of BP recombination reaction 
The BP Recombination Reaction was used to transform competent E. coli One Shot® TOP10 
Chemically Competent Cells (Life Technologies). A 50 μL aliquot of competent cells was 
defrosted and incubated on ice for thirty min with 1 μL of the reaction mixture. The cells 
were then heat shocked for thirty sec at 42 °C and immediately transferred to ice before 250 
μL of room temperature super optimal broth (SOC) was added. The cells were incubated at 
37 °C for one hour with shaking at 180 rpm before being spread on pre-warmed LB-Kan 
plates and left to grow overnight at 37 °C. 
 
5.3.5 DNA sequencing 
DNA sequencing services were provided by Canterbury Sequencing and Genotyping based at 
the University of Canterbury. Sequencing was carried out using an Applied Biosystems 
3130xl Genetic Analyser and BigDye Terminator v3.1 (Applied Biosystems) used for the 
sequencing chemistry. Approximately 250 ng of purified double-stranded plasmid and 3.2 
μM of primer were supplied for each sample. 
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5.3.6 LR recombination reaction into destination vectors 
Once DNA sequencing results confirmed that the entry vector contained the gene of 
interest, Gateway® LR Clonase® II enzyme mix was used to catalyse the recombination 
reaction between pDONR 221 (entry vector containing the gene of interest with attL sites), 
and the destination vector of choice (pDEST 17-His-tag for GspDAH7PSDAH7PS and pDEST15-
GST-tag for GspDAH7PSCM) containing the attR sites. 
The reaction was carried out by pDONR 221 plasmid (entry vector) containing the gene of 
interest (approximately 104 ng for GspDAH7PSDAH7PS and 102 ng for GspDAH7PSCM), 150 ng 
of desired destination vector and adding TE buffer (pH 8) to the reaction components to 
equal 8 µL total volume. The reaction is initiated with the addition of LR clonase, and then 
incubated a 25 ᵒC for one hour before halting the reaction with the addition of proteinase K 
and incubating the reaction mixture at 37 ᵒC for ten min. 
 
5.3.7 Transformation of LR recombination reaction 
The vectors bearing the genes of GspDAH7PSDAH7PS and GspDAH7PSCM were transformed 
into E. coli chaperone 3 cells and E. coli BL21 (DE3) cells respectively. 50 μL aliquots of 
competent cells was defrosted and incubated on ice for thirty min with 1 μL of the reaction 
mixtures. The cells were then heat-shocked for thirty sec at 42 °C and immediately 
transferred to ice before 250 μL of room temperature SOC medium was added. The cells 
were incubated at 37 °C for one hour with shaking (180 rpm) before being spread on pre-
warmed LB with the appropriate antibiotics added for E. coli BL21(DE3)  and E. coli 
chaperone 3 cells. Plates were left to grow overnight at 37 °C. 
 
5.3.8 Plasmid extraction 
5 mL cultures were grown for all plasmid extractions. Cultures had the required antibiotics 
added, inoculated from glycerol stocks and left overnight at 37 ᵒC to grow. Cells were 
harvested and plasmid extracted using High Pure Plasmid Isolation kit (Roche). The 
Nanodrop-1000 spectrophotometer was used to determine the concentration of the 
isolated plasmid at 260 nm.  
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5.3.9 Transformation 
Chemically competent cells (50 μL) were thawed on ice before the addition of 2 μL of either 
purified PCR product or extracted plasmid. The mixture was left on ice for a further thirty 
min before the cells were heat-shocked at 42 °C for thirty sec to forty five sec. The cells 
were then replaced on ice for two min before the addition of 250 μL of SOC medium (2 % 
(w/v) tryptone, 0.5 % (w/v) yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM MgSO4 and 20 
mM glucose, filter sterilised) and outgrown at 37 °C for one hour with shaking (200 rpm). An 
aliquot of transformed cells (75 μL to 200 μL) was spread directly onto a pre-warmed LB-
agar plate containing the appropriate antibiotics and left to grow overnight, inverted, at 37 
°C. 
 
5.3.10 Glycerol stocks 
Once a cell colony carrying a desired gene was obtained, a 5 mL culture was grown from the 
colony at 37 ᵒC overnight. 750 µL was taken from the culture and mixed with 250 µL of 80 % 
sterilised glycerol to give a final concentration of 20 % (v/v) in a sterile 1.7 mL 
microcentrifuge tube, flash frozen with liquid nitrogen and stored at 80 ᵒC.  
 
5.3.11 Media 
Cultures were grown in LB (Lennox L) solution made up with milliQ water (20 g/L).  LB 
powder was also used in the making of LB Agar plates used for growing cells. Agar (25 g/L) 
was mixed with LB powder (20 g/L), and milliQ water and then autoclaved and left to cool. 
Before using the LB agar, it was heated until all solid was dissolved then incubated at 60 ᵒC 
for equilibration to occur. Solution was left to cool to avoid antibiotic degradation upon 
addition and then the solution was poured into Agar plates. 
Once the transformation step of E. coli cells was carried out, SOC media was added and cells 
were then incubated at 37 ᵒC for one hour with shaking before being plated.  
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5.3.12 Purification using nickel affinity column  
After cell lysis (for GspDAH7PSWT and GspDAH7PSDAH7PS), and the separation of the 
supernatant from the lysed cells by centrifugation, the supernatant was loaded to a HisTrap 
HP (GE Healthcare) that had been pre equilibrated with the binding buffer (20 mM sodium 
phosphate, 0.5 M NaCl, 20 mM imidazole, pH 7.4), then eluted with the elution buffer (20 
mM sodium phosphate, 0.5 M NaCl, 500 mM imidazole, pH 7.4). Eluted fractions of 
GspDAH7PSDAH7PS were collected and desalted before the removal of the His-tag using TEV 
protease. Once TEV protease was added, the mixture was left overnight at 4 ᵒC and then left 
at room temperature for one hour before being reloaded to a HisTrap HP (GE Healthcare) 
equilibrated with binding buffe. The protein eluted in the flow through, and was 
concentrated using a 20 ml 10 000 Da MWCO device (Sartorius Stedim Biotech), and loaded 
onto a Superdex S200 26/60 SEC column. 
 
5.3.13 Purification using GST affinity chromatography 
After cell lysis (for GspDAH7PSCM), and the separation of the supernatant from the lysed 
cells by centrifugation, the supernatant was loaded to a GSTrap (GE Healthcare) that had 
been pre equilibrated with PBS binding buffer (140 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.8 mM KH2PO4 pH 7.3) and eluted with the elution buffer (50 mM tris-HCl, 10 mM reduced 
glutathione, pH 8.0) through a linear gradient. Eluted fractions of GspDAH7PSCM were 
collected and buffer exchanged into binding buffer before the removal of the GST-tag using 
TEV protease. Once TEV protease was added, the mixture was left overnight at 4 ᵒC, then 
left at room temperature for one hour before being reloaded to a the GSTrap (GE 
Healthcare) equilibrated with binding buffer.  The protein eluted in the flow through, and 
was concentrated using a 20 ml 5000 kDa MWCO device (Sartorius Stedim Biotech) before 
being loaded onto a Superdex 75 16/60 SEC column (GE Healthcare). 
 
5.3.14 N-terminal His-tag and GST-tag removal using TEV protease 
Fractions containing DAH7PS, as determined by SDS-PAGE, were pooled and washed with 
loading buffer using a desalting column to remove any imidazole or glutathione. The protein 
107 
 
was then incubated for up to 24 h at 4 ᵒC with recombinant TEV protease (1 OD 280 of TEV 
protease per 10 OD 280 proteins). The completeness of cleavage was assessed by SDS-PAGE. 
The rTEV was successfully removed in the next step of purification by reapplication to 
HisTrap HP or GSTrap column (GE Healthcare).  
 
5.3.15 Protein secondary structure analysis 
CD spectra measurements were performed using a JASCO J-815 spectrophotometer. 
Wavelength scans were carried out in double-distilled water (pH 7.0) between wavelengths 
180-240 nm, with 0.5 data pitch, one sec response and 1 mm bandwidth at room 
temperature. Samples were prepared at an enzyme concentration of 0.15 mg/ml 
 
5.3.16 Metal activation  
The metal activation profile of GspDAH7PSDAH7PS was determined using standard assays with 
195 µM PEP and 197 µM E4P in 50 mM BTP buffer Chelex®-treated and filtered, pH 6.8 at 60 
ᵒC and 100 µM Cd2+, Mn2+, Mg2+, Zn2+, Ni2+, Co2+, EDTA, DPA or no condition (control). The 
enzyme (5 µL at 0.13 mg/mL) was incubated and left to equilibrate with the reaction 
mixture for five min at 60 ᵒC prior to activation with E4P, to a final volume of 1 mL. Triplicate 
assays were performed. 
 
5.3.17 Temperature dependency study of GspDAH7PSDAH7PS 
The temperature dependency profile of GspDAH7PSDAH7PS was determined using standard 
assays. Substrate concentrations were kept constant with 337 µM PEP and 356 µM E4P in 
50 mM BTP buffer Chelex®-treated and filtered, pH 6.8 at the desired temperature with 100 
µM Cd2+. The reaction mixture was left to equilibrate at the chosen temperature. At each 
temperature (30 °C, 40 °C, 50 °C, 60 °C, 70 °C and 80 °C), the enzyme, 3 µL at 0.14 mg/mL 
(1.4x10-2 µM in cuvette) was then incubated and left to equilibrate with the reaction 
mixture for either one or five min prior to activation with E4P, to a final volume of 1 mL. 
Triplicate assays were performed. 
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5.3.18 Temperature dependency study of GspDAH7PSCM 
The temperature dependency profile of GspDAH7PSCM was determined using standard 
assays. The substrate concentration was kept constant with 80 µM CA in 50 mM BTP buffer 
Chelex®-treated and filtered, pH 6.8 at the desired temperature. The reaction mixture was 
left to equilibrate at the chosen temperature. At each temperature (30 °C, 40 °C, 50 °C, 60 
°C, 70 °C and 80 °C), the enzyme, 5 µL at 5.29 mg/mL (2.4 µM in cuvette) was then 
incubated and left to equilibrate with the reaction mixture for either one or five min prior to 
activation with CA, to a final volume of 1 mL. Triplicate assays were performed. 
 
5.3.19 Michaelis-Menten kinetics for GspDAH7PSDAH7PS 
The assays for determining the kinetic parameters for GspDAH7PSDAH7PS were carried out in 
1 cm path length quartz cuvettes. Standard reaction mixtures contained 100 µM Cd2+, 5 µL 
protein at 0.11 mg/mL (1.8x10-2 µM in cuvette) enzyme in 50 mM BTP buffer (pH 6.8), giving 
a total volume of 1 mL. To determine the Km
E4P, the PEP concentration was fixed at 332 µM 
while the E4P concentration was varied (7 µM to 392 µM). For the determination of Km
PEP, 
E4P concentration was fixed at 324 µM while PEP concentration was varied (12 µM to 354 
µM). 
 
5.3.20 Michaelis-Menten kinetics for GspDAH7PSCM 
The assays for determining the kinetic parameters for GspDAH7PSCM were carried out in 1 
mm path length quartz cuvettes. Standard reaction mixtures contained 5 µL enzyme at 0.47 
mg/mL (0.84 µM in cuvette) in 50mM BTP buffer (pH 6.8), giving a total volume of 250 µL. 
To determine the Km
CA different concentrations of CA were used varying from (54 µM to 
1632 µM). 
 
5.3.21 CM assay 
Steady-state kinetics were measured using a continuous assay monitoring the 
disappearance of chorismate at 274 nm at 50 °C (extinction coefficient at 274 nm of 2630 M-
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1 cm-1 at 50 °C and pH 6.8) in 50 mM BTP buffer (Chelex®-treated and filtered). Reaction 
mixtures were made to a final volume of 1 mL and were initiated with the addition of CA at 
a desired concentration. Initial velocities for the catalytic chorismate mutase activity were 
measured by initiating the equilibrated reaction mixture with varying concentrations of CA. 
GraFit (Erithacus Software) was used to fit initial reaction velocities to the Michaelis-Menten 
equation. An accurate CA substrate concentration was obtained by using a standard assay 
system. The reaction mixture was made up of enzyme, 50 mM BTP buffer (pH 6.8), enzyme 
and 10 μL CA, adding up to a total volume of 1 mL. Beer-Lambert’s Law was used to 
determine the concentration of CA (A = ɛ c l, where l = 1 cm and ɛ of 2630 M-1 cm-1 at 50 ᵒC) 
by determining the change in absorbance prior to the addition of enzyme and after the 
addition of enzyme when the reaction had reached completion (ΔA1). A control reaction, 
where CA is absent, was used to determine the change in absorbance caused by the 
addition of enzyme (ΔA2). This gave the total change in absorbance (ΔA1 + ΔA2) and was 
converted to give a more accurate substrate concentration. 
 
5.3.22 Feedback inhibition of GspDAH7PSDAH7PS 
The inhibition profile of GspDAH7PSDAH7PS was determined using standard assays. Varying 
concentrations of PA were added to make a 1 mL solution consisting of Chelex®-treated and 
filtered 50 mM BTP buffer (pH 6.8 at 60 ᵒC), Cd2+ (100 µM), PEP (121 µM) and enzyme (7 µM 
at 0.08 mg/mL). The reaction mixture was incubated at 60 ᵒC for ten min to equilibrate prior 
to initiating the reaction by addition of E4P (123 µM). All reactions were performed in 
triplicate. 
 
5.3.23 Analytical SEC 
For analytical SEC, the column (Superdex 10/300 GL) was calibrated using known standards 
to determine the elution volume to mass relationship. Six protein standards; ovalbumin (44 
kDa), conalbumin (75 kDa), aldolase (158 kDa), ferritin (440 kDa), thyroglobulin (669 kDa) 
and blue dextran (2000 kDa), were dissolved in running buffer (same as SEC buffer) and 
applied to the column. The column was equilibrated with running buffer at a set flow rate of 
0.2 mL/min. GspDAH7PSDAH7PS samples (500 μL volume at 1 mg/mL and 0.5 mg/mL) were 
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injected onto the equilibrated column and eluted from column using running buffer. After 
proteins were eluted, the column was equilibrated again for the next run. The peak 
corresponding to blue dextran was recorded as void volume. The highest point of the 
protein sample peak was recorded as the elution volume. Elution volumes were recorded 
and graphed against the log (mass protein standard (Da)). This created a linear graph from 
which unknown protein masses could be determined. 
 
5.3.24 Analytical ultracentrifugation 
Sedimentation velocity and sedimentation equilibrium experiments were performed in a 
Beckman Coulter Model XL-I analytical ultracentrifuge equipped with UV/Vis scanning 
optics. Reference buffer solution (10 mM BTP, pH 7.4, 40 mM KCl, 200 µM PEP and 10 µM 
EDTA) and sample solutions were loaded into 12 mm double-sector cells with quartz 
windows. The cells were then mounted in an An-60 Ti 4-hole rotor.   
 
Samples at an initial protein concentration of 1.8 mg/mL, 1 mg/mL and 0.5 mg/mL (380 μL) 
and reference (400 μL) were centrifuged at 50,000 rpm at 20 °C and absorbance data were 
collected in continuous mode at 278 nm without averaging. Data were fitted to a 
continuous size distribution model using the program SEDFIT. The partial specific volume (v) 
of the sample (0.7463 mL g−1), buffer density (1.0004 g mL−1) and buffer viscosity (1.004 cP) 
were calculated using the program SEDNTERP.  
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